JP2011527667A - ハロ置換ピリミドジアゼピン - Google Patents
ハロ置換ピリミドジアゼピン Download PDFInfo
- Publication number
- JP2011527667A JP2011527667A JP2011513994A JP2011513994A JP2011527667A JP 2011527667 A JP2011527667 A JP 2011527667A JP 2011513994 A JP2011513994 A JP 2011513994A JP 2011513994 A JP2011513994 A JP 2011513994A JP 2011527667 A JP2011527667 A JP 2011527667A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- tetrahydro
- difluoro
- pyrimido
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- OHXQYFCNXHGKPJ-UHFFFAOYSA-N 1h-pyrimido[5,4-c]diazepine Chemical class N1N=CC=CC2=NC=NC=C12 OHXQYFCNXHGKPJ-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 506
- 150000001875 compounds Chemical class 0.000 claims abstract description 73
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 10
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims abstract description 6
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 230000000771 oncological effect Effects 0.000 claims abstract description 6
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 5
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 5
- 206010009944 Colon cancer Diseases 0.000 claims abstract description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 5
- 206010060862 Prostate cancer Diseases 0.000 claims abstract description 5
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 5
- 208000029742 colonic neoplasm Diseases 0.000 claims abstract description 5
- 201000005202 lung cancer Diseases 0.000 claims abstract description 5
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 5
- -1 — (CH 2 ) n -aryl Chemical group 0.000 claims description 383
- 125000000217 alkyl group Chemical group 0.000 claims description 41
- 239000001257 hydrogen Substances 0.000 claims description 36
- 229910052739 hydrogen Inorganic materials 0.000 claims description 36
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 19
- ZKMVETCPEOLGKX-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethylbenzoic acid Chemical compound CCC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 ZKMVETCPEOLGKX-UHFFFAOYSA-N 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 16
- 125000001153 fluoro group Chemical group F* 0.000 claims description 16
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 15
- ZSJCKAGQFMQYPN-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=C(F)C=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 ZSJCKAGQFMQYPN-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- CMDYKXOHCXFFEY-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-(trifluoromethyl)benzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(O)=O)C=C1C(F)(F)F CMDYKXOHCXFFEY-UHFFFAOYSA-N 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- DKKARFAGKSXUOQ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxybenzoic acid Chemical compound CCOC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 DKKARFAGKSXUOQ-UHFFFAOYSA-N 0.000 claims description 11
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 11
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 11
- GWRSATNRNFYMDI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C)CC1 GWRSATNRNFYMDI-UHFFFAOYSA-N 0.000 claims description 10
- MYXKWQBFWLFLRL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(N)=O)C=C1C MYXKWQBFWLFLRL-UHFFFAOYSA-N 0.000 claims description 10
- APUDYQSELWZNKJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methylbenzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(O)=O)C=C1C APUDYQSELWZNKJ-UHFFFAOYSA-N 0.000 claims description 10
- CRWJVMVXFUPDSV-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 CRWJVMVXFUPDSV-UHFFFAOYSA-N 0.000 claims description 9
- DUMGSMIYUOAUKI-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzoic acid Chemical compound N1=C2N(C3CCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(O)=O)C=C1 DUMGSMIYUOAUKI-UHFFFAOYSA-N 0.000 claims description 9
- AYZQTNNTQIVZBF-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(O)=O)C=C1OC AYZQTNNTQIVZBF-UHFFFAOYSA-N 0.000 claims description 9
- CIFKUDOYFQJFNR-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 CIFKUDOYFQJFNR-UHFFFAOYSA-N 0.000 claims description 9
- PHHUAAGQVSFMPP-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(O)=O)C=C1 PHHUAAGQVSFMPP-UHFFFAOYSA-N 0.000 claims description 8
- UBNNIDJLSKXXAD-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 UBNNIDJLSKXXAD-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- BNUJZZKCRYZJRK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(O)=O)C=C1 BNUJZZKCRYZJRK-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- HBMAHAVOKSITSJ-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCOCC1 HBMAHAVOKSITSJ-UHFFFAOYSA-N 0.000 claims description 6
- AVOQOBYXRVYWBE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluorobenzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(O)=O)C=C1F AVOQOBYXRVYWBE-UHFFFAOYSA-N 0.000 claims description 6
- SUBIEWLFZOKEFV-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(O)=O)C=C1 SUBIEWLFZOKEFV-UHFFFAOYSA-N 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- ZCBNVAGNECOCMF-UHFFFAOYSA-N tert-butyl 3-[[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]methyl]pyrrolidine-1-carboxylate Chemical compound COC1=CC(C(=O)NCC2CN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 ZCBNVAGNECOCMF-UHFFFAOYSA-N 0.000 claims description 6
- WUXFUFZPNVCASY-UHFFFAOYSA-N tert-butyl 4-[3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]propyl]piperazine-1-carboxylate Chemical compound COC1=CC(C(=O)NCCCN2CCN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 WUXFUFZPNVCASY-UHFFFAOYSA-N 0.000 claims description 6
- UVIZGRDPUZKCBS-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]piperidine-1-carboxylate Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 UVIZGRDPUZKCBS-UHFFFAOYSA-N 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- CXNVFCSEWWAJON-UHFFFAOYSA-N 2-[4-(4-aminopiperidine-1-carbonyl)-2-methoxyanilino]-9-cyclobutyl-7,7-difluoro-5-methyl-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound COC1=CC(C(=O)N2CCC(N)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCC1 CXNVFCSEWWAJON-UHFFFAOYSA-N 0.000 claims description 5
- IUJQPSWSRGBVJW-UHFFFAOYSA-N 3-chloro-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1Cl)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 IUJQPSWSRGBVJW-UHFFFAOYSA-N 0.000 claims description 5
- WEHVNKBYLJCMMJ-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCC1 WEHVNKBYLJCMMJ-UHFFFAOYSA-N 0.000 claims description 5
- FBOOQQSTUJIFAM-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 FBOOQQSTUJIFAM-UHFFFAOYSA-N 0.000 claims description 5
- ULDARIOAPUUKJG-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-piperidin-4-ylbenzamide Chemical compound COC1=CC(C(=O)NC2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCC1 ULDARIOAPUUKJG-UHFFFAOYSA-N 0.000 claims description 5
- PMVOUTHKCYEMPQ-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-3-methoxybenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1OC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 PMVOUTHKCYEMPQ-UHFFFAOYSA-N 0.000 claims description 5
- NFUNSBDLHHIBSL-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 NFUNSBDLHHIBSL-UHFFFAOYSA-N 0.000 claims description 5
- XSZUPBHQHPFDSL-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 XSZUPBHQHPFDSL-UHFFFAOYSA-N 0.000 claims description 5
- QXWJUCOMFHDLPF-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]benzamide Chemical compound C1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 QXWJUCOMFHDLPF-UHFFFAOYSA-N 0.000 claims description 5
- PGHBBDMNKBAQNE-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 PGHBBDMNKBAQNE-UHFFFAOYSA-N 0.000 claims description 5
- RRBKFQWILURZSY-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]benzamide Chemical compound C1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 RRBKFQWILURZSY-UHFFFAOYSA-N 0.000 claims description 5
- IVXWOETVECBJHF-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-piperidin-4-ylbenzamide Chemical compound N1=C2N(C3CCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCNCC1 IVXWOETVECBJHF-UHFFFAOYSA-N 0.000 claims description 5
- NDUUNZYFHCECHM-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzamide Chemical compound N1=C2N(C3CCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(N)=O)C=C1 NDUUNZYFHCECHM-UHFFFAOYSA-N 0.000 claims description 5
- RUOIOJYKNJAUQV-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC(C(=C1)OC)=CC=C1C(=O)NC1CCN(C)CC1 RUOIOJYKNJAUQV-UHFFFAOYSA-N 0.000 claims description 5
- YQNSTWINJRVYTB-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(=O)NC)C=C1OC YQNSTWINJRVYTB-UHFFFAOYSA-N 0.000 claims description 5
- MCUKECQUPXGEMT-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(N)=O)C=C1OC MCUKECQUPXGEMT-UHFFFAOYSA-N 0.000 claims description 5
- KVBRBWXEQBACPD-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCOCC1 KVBRBWXEQBACPD-UHFFFAOYSA-N 0.000 claims description 5
- RHZKFRVTDFPYRR-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(=O)NCCCN(C)C)C=C1OC RHZKFRVTDFPYRR-UHFFFAOYSA-N 0.000 claims description 5
- FWGVXQRBROHEEF-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-methylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(=O)NC)C=C1 FWGVXQRBROHEEF-UHFFFAOYSA-N 0.000 claims description 5
- VVMNBLKDKMMETH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-(oxan-4-yl)benzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCOCC1 VVMNBLKDKMMETH-UHFFFAOYSA-N 0.000 claims description 5
- AVIARCKQBCAZBH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-methylbenzamide Chemical compound C1=C(F)C(C(=O)NC)=CC(OC)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 AVIARCKQBCAZBH-UHFFFAOYSA-N 0.000 claims description 5
- ODVBAYANYQNILT-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-piperidin-4-ylbenzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCNCC1 ODVBAYANYQNILT-UHFFFAOYSA-N 0.000 claims description 5
- GQJXXADLKQPPTK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=C(F)C=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 GQJXXADLKQPPTK-UHFFFAOYSA-N 0.000 claims description 5
- WHOINWVKRUBFPQ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-(trifluoromethyl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(N)=O)C=C1C(F)(F)F WHOINWVKRUBFPQ-UHFFFAOYSA-N 0.000 claims description 5
- KSQCIWNAZLUWQK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxy-n-(1-ethylpiperidin-4-yl)benzamide Chemical compound CCOC1=CC(C(=O)NC2CCN(CC)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 KSQCIWNAZLUWQK-UHFFFAOYSA-N 0.000 claims description 5
- HQBLKFSTQFDCHI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound CCOC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 HQBLKFSTQFDCHI-UHFFFAOYSA-N 0.000 claims description 5
- RDEVSZJYXCOMKE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethyl-n-(1-ethylpiperidin-4-yl)benzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1CC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 RDEVSZJYXCOMKE-UHFFFAOYSA-N 0.000 claims description 5
- XCXUJMZIPNJQGW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethyl-n-(1-methylpiperidin-4-yl)benzamide Chemical compound CCC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 XCXUJMZIPNJQGW-UHFFFAOYSA-N 0.000 claims description 5
- RPFAZEOEDWRAOL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethyl-n-methylbenzamide Chemical compound CCC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 RPFAZEOEDWRAOL-UHFFFAOYSA-N 0.000 claims description 5
- OQFJJHMUDNKYGT-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylazetidin-3-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CN(C)C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 OQFJJHMUDNKYGT-UHFFFAOYSA-N 0.000 claims description 5
- DJNZZLZKAXGMMC-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 DJNZZLZKAXGMMC-UHFFFAOYSA-N 0.000 claims description 5
- SSGFRFHOPDHRLJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-phenylethyl)benzamide Chemical compound COC1=CC(C(=O)NC(C)C=2C=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 SSGFRFHOPDHRLJ-UHFFFAOYSA-N 0.000 claims description 5
- PPSWWWMGJLWMQP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2,2,6,6-tetramethylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CC(C)(C)NC(C)(C)C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 PPSWWWMGJLWMQP-UHFFFAOYSA-N 0.000 claims description 5
- REFUJAXKLCTSJG-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2-piperidin-1-ylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCN2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 REFUJAXKLCTSJG-UHFFFAOYSA-N 0.000 claims description 5
- BZMPOAXTVCJMPA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(3-methoxypiperidin-4-yl)benzamide Chemical compound COC1CNCCC1NC(=O)C(C=C1OC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 BZMPOAXTVCJMPA-UHFFFAOYSA-N 0.000 claims description 5
- QWDOEQFTIIFGRO-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[1-(3-methylsulfonylpropyl)piperidin-4-yl]benzamide Chemical compound COC1=CC(C(=O)NC2CCN(CCCS(C)(=O)=O)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 QWDOEQFTIIFGRO-UHFFFAOYSA-N 0.000 claims description 5
- MUQIJSDCRJKAOW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[2-(1-methylpyrrolidin-2-yl)ethyl]benzamide Chemical compound COC1=CC(C(=O)NCCC2N(CCC2)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 MUQIJSDCRJKAOW-UHFFFAOYSA-N 0.000 claims description 5
- OFLJIARPXSOEFR-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[3-(2-oxopyrrolidin-1-yl)propyl]benzamide Chemical compound COC1=CC(C(=O)NCCCN2C(CCC2)=O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 OFLJIARPXSOEFR-UHFFFAOYSA-N 0.000 claims description 5
- VJZCQHMPYHGUHW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[[4-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound COC1=CC(C(=O)NCC=2C=CC(=CC=2)C(F)(F)F)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 VJZCQHMPYHGUHW-UHFFFAOYSA-N 0.000 claims description 5
- VHFRRQFMCDERFH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-phenylbenzamide Chemical compound COC1=CC(C(=O)NC=2C=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 VHFRRQFMCDERFH-UHFFFAOYSA-N 0.000 claims description 5
- SHBWZOHGEVPNGK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-piperidin-4-ylbenzamide Chemical compound COC1=CC(C(=O)NC2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 SHBWZOHGEVPNGK-UHFFFAOYSA-N 0.000 claims description 5
- GAQLGMAZHNCUEH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methyl-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 GAQLGMAZHNCUEH-UHFFFAOYSA-N 0.000 claims description 5
- NKWDWRQAIWLVQX-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n,3-dimethylbenzamide Chemical compound CC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 NKWDWRQAIWLVQX-UHFFFAOYSA-N 0.000 claims description 5
- GGTRXLGNWTVQMQ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-cyclopentylpiperidin-4-yl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C2CCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 GGTRXLGNWTVQMQ-UHFFFAOYSA-N 0.000 claims description 5
- AOGYILPAZJWWEO-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-cyclopropylpiperidin-4-yl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C2CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 AOGYILPAZJWWEO-UHFFFAOYSA-N 0.000 claims description 5
- OWBPCPUOKHELBW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-3-(trifluoromethyl)benzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1C(F)(F)F)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 OWBPCPUOKHELBW-UHFFFAOYSA-N 0.000 claims description 5
- QFLZTKMRVNTGQH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-3-methoxybenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1OC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 QFLZTKMRVNTGQH-UHFFFAOYSA-N 0.000 claims description 5
- IDFLZBNSRJTOPH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-3-methylbenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 IDFLZBNSRJTOPH-UHFFFAOYSA-N 0.000 claims description 5
- FKHRYUDFWFPNRM-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)-3-(trifluoromethoxy)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1OC(F)(F)F)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 FKHRYUDFWFPNRM-UHFFFAOYSA-N 0.000 claims description 5
- AGZWLPUVHFMVLT-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)-3-propan-2-yloxybenzamide Chemical compound CC(C)OC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 AGZWLPUVHFMVLT-UHFFFAOYSA-N 0.000 claims description 5
- HTIHGFRFJHRDCL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(2-ethoxyethyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCOCC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 HTIHGFRFJHRDCL-UHFFFAOYSA-N 0.000 claims description 5
- GQVQPKONQLVQPF-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(3-imidazol-1-ylpropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN2C=NC=C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 GQVQPKONQLVQPF-UHFFFAOYSA-N 0.000 claims description 5
- NRXNHAUTZNKJGS-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(4-hydroxybutyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCCO)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 NRXNHAUTZNKJGS-UHFFFAOYSA-N 0.000 claims description 5
- JKYXXSSNVGHEJH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(oxan-4-yl)-3-(trifluoromethyl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)C(F)(F)F)=CC=C1C(=O)NC1CCOCC1 JKYXXSSNVGHEJH-UHFFFAOYSA-N 0.000 claims description 5
- MHVTYJIOWYEMEU-IEBWSBKVSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[(3r,4r)-4-hydroxypyrrolidin-3-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)N[C@H]2[C@@H](CNC2)O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 MHVTYJIOWYEMEU-IEBWSBKVSA-N 0.000 claims description 5
- NCMKGIMDIXOHPG-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[1-(2-fluoroethyl)piperidin-4-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CCF)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 NCMKGIMDIXOHPG-UHFFFAOYSA-N 0.000 claims description 5
- WZCBUMSLQRGNHI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 WZCBUMSLQRGNHI-UHFFFAOYSA-N 0.000 claims description 5
- JJRBPPFLTOPESW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(4-hydroxypiperidin-1-yl)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN2CCC(O)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 JJRBPPFLTOPESW-UHFFFAOYSA-N 0.000 claims description 5
- LRMZEFKMUKWUIH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)-2,2-dimethylpropyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC(C)(C)CN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 LRMZEFKMUKWUIH-UHFFFAOYSA-N 0.000 claims description 5
- MMZDWEJLOAGTJA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-2-fluoro-5-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=C(F)C=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 MMZDWEJLOAGTJA-UHFFFAOYSA-N 0.000 claims description 5
- LYZWISCMBGUXGE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 LYZWISCMBGUXGE-UHFFFAOYSA-N 0.000 claims description 5
- MHKLTXHSWNNYJZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN2CCN(CCO)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 MHKLTXHSWNNYJZ-UHFFFAOYSA-N 0.000 claims description 5
- RGMABEIKUYJTJO-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-methyl-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 RGMABEIKUYJTJO-UHFFFAOYSA-N 0.000 claims description 5
- BTDBBVCKFAZCGE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-piperidin-4-yl-3-(trifluoromethyl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)C(F)(F)F)=CC=C1C(=O)NC1CCNCC1 BTDBBVCKFAZCGE-UHFFFAOYSA-N 0.000 claims description 5
- TXZJHBVAUZZCIV-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 TXZJHBVAUZZCIV-UHFFFAOYSA-N 0.000 claims description 5
- JIJBYSBXCDZJOF-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(oxan-4-yl)benzamide Chemical compound C12=NC(NC=3C=CC(=CC=3)C(=O)NC3CCOCC3)=NC=C2NC(=O)C(F)(F)CN1C1CCCC1 JIJBYSBXCDZJOF-UHFFFAOYSA-N 0.000 claims description 5
- WDWPFFDRGWGKTA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 WDWPFFDRGWGKTA-UHFFFAOYSA-N 0.000 claims description 5
- SNFFXIKTYVRJJT-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 SNFFXIKTYVRJJT-UHFFFAOYSA-N 0.000 claims description 5
- GPLDKLIAVDXEJD-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC(C(=C1)OC)=CC=C1C(=O)NC1CCN(C)CC1 GPLDKLIAVDXEJD-UHFFFAOYSA-N 0.000 claims description 5
- YLSMPWWVVOLKEX-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(=O)NC)C=C1OC YLSMPWWVVOLKEX-UHFFFAOYSA-N 0.000 claims description 5
- TTXPBUDDEYMKHD-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(N)=O)C=C1OC TTXPBUDDEYMKHD-UHFFFAOYSA-N 0.000 claims description 5
- VMTJUFZAQPHXEE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(=O)NCCCN(C)C)C=C1OC VMTJUFZAQPHXEE-UHFFFAOYSA-N 0.000 claims description 5
- FJOUCLBBJFWXSP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-methylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(=O)NC)C=C1 FJOUCLBBJFWXSP-UHFFFAOYSA-N 0.000 claims description 5
- RJSCKYMFABFIIC-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(N)=O)C=C1 RJSCKYMFABFIIC-UHFFFAOYSA-N 0.000 claims description 5
- JGXHMSFNMFZFLG-UHFFFAOYSA-N 4-[[9-cyclopentyl-7,7-difluoro-6-oxo-5-(2,2,2-trifluoroethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(CC(F)(F)F)C(=O)C(F)(F)CN2C1CCCC1 JGXHMSFNMFZFLG-UHFFFAOYSA-N 0.000 claims description 5
- HWDBPLXCHQEMRD-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-[3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]propyl]carbamate Chemical compound COC1=CC(C(=O)NCCCNC(=O)OCC2C3=CC=CC=C3C3=CC=CC=C32)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 HWDBPLXCHQEMRD-UHFFFAOYSA-N 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- ITEZHQFBMXTVNV-UHFFFAOYSA-N methyl 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxybenzoate Chemical compound C1=C(F)C(C(=O)OC)=CC(OC)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 ITEZHQFBMXTVNV-UHFFFAOYSA-N 0.000 claims description 5
- DVWLYDMAMWHJQE-UHFFFAOYSA-N n-(1-acetylpiperidin-4-yl)-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C(C)=O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 DVWLYDMAMWHJQE-UHFFFAOYSA-N 0.000 claims description 5
- URLSPPAAXZIPQQ-UHFFFAOYSA-N n-(1-benzylpiperidin-4-yl)-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC=3C=CC=CC=3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 URLSPPAAXZIPQQ-UHFFFAOYSA-N 0.000 claims description 5
- ZYZNGWOTBSRQRZ-UHFFFAOYSA-N n-[3-(cyclohexylamino)propyl]-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCNC2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 ZYZNGWOTBSRQRZ-UHFFFAOYSA-N 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- SRRVBDKOWVGKSP-LJQANCHMSA-N tert-butyl (3r)-3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]pyrrolidine-1-carboxylate Chemical compound COC1=CC(C(=O)N[C@H]2CN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 SRRVBDKOWVGKSP-LJQANCHMSA-N 0.000 claims description 5
- VGFCEGXMJRFFPC-UHFFFAOYSA-N tert-butyl 3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]azetidine-1-carboxylate Chemical compound COC1=CC(C(=O)NC2CN(C2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 VGFCEGXMJRFFPC-UHFFFAOYSA-N 0.000 claims description 5
- SDHDTPJXPNWEJQ-UHFFFAOYSA-N tert-butyl 3-[[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]methyl]azetidine-1-carboxylate Chemical compound COC1=CC(C(=O)NCC2CN(C2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 SDHDTPJXPNWEJQ-UHFFFAOYSA-N 0.000 claims description 5
- XJSVIHIQQOGDKK-UHFFFAOYSA-N 2-[4-(4-aminopiperidine-1-carbonyl)anilino]-9-cyclobutyl-7,7-difluoro-5-methyl-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound N1=C2N(C3CCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C=C1)=CC=C1C(=O)N1CCC(N)CC1 XJSVIHIQQOGDKK-UHFFFAOYSA-N 0.000 claims description 4
- SOFNFHDUACNLQO-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 SOFNFHDUACNLQO-UHFFFAOYSA-N 0.000 claims description 4
- QHZJGPRXYWGMML-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCC3)C2=N1 QHZJGPRXYWGMML-UHFFFAOYSA-N 0.000 claims description 4
- VGBLKNGMQCWXDU-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC(C(=C1)OC)=CC=C1C(=O)NC1CCOCC1 VGBLKNGMQCWXDU-UHFFFAOYSA-N 0.000 claims description 4
- VZUVZFKLXAGIGF-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCN(C)CC1 VZUVZFKLXAGIGF-UHFFFAOYSA-N 0.000 claims description 4
- QGVDUOVUPWJDJK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxy-n-(oxan-4-yl)benzamide Chemical compound CCOC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 QGVDUOVUPWJDJK-UHFFFAOYSA-N 0.000 claims description 4
- ASJBKOWVWPCRCF-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethyl-n-(oxan-4-yl)benzamide Chemical compound CCC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 ASJBKOWVWPCRCF-UHFFFAOYSA-N 0.000 claims description 4
- JEXBNPMDDPNUAM-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethyl-n-piperidin-4-ylbenzamide Chemical compound CCC1=CC(C(=O)NC2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 JEXBNPMDDPNUAM-UHFFFAOYSA-N 0.000 claims description 4
- IHCXVPRBNKTTST-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(pyridin-2-ylmethyl)benzamide Chemical compound COC1=CC(C(=O)NCC=2N=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 IHCXVPRBNKTTST-UHFFFAOYSA-N 0.000 claims description 4
- QVIMVYQXQPICTI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[3-(2-methylpiperidin-1-yl)propyl]benzamide Chemical compound COC1=CC(C(=O)NCCCN2C(CCCC2)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 QVIMVYQXQPICTI-UHFFFAOYSA-N 0.000 claims description 4
- VNLUXOVXQNANKP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-piperidin-1-ylbenzamide Chemical compound COC1=CC(C(=O)NN2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 VNLUXOVXQNANKP-UHFFFAOYSA-N 0.000 claims description 4
- PMRVLWKZCJBMKA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methyl-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)C)=CC=C1C(=O)NC1CCOCC1 PMRVLWKZCJBMKA-UHFFFAOYSA-N 0.000 claims description 4
- OAXMQNLWOHOQLY-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methyl-n-piperidin-4-ylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)C)=CC=C1C(=O)NC1CCNCC1 OAXMQNLWOHOQLY-UHFFFAOYSA-N 0.000 claims description 4
- BAVKHKJJAGWXBX-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 BAVKHKJJAGWXBX-UHFFFAOYSA-N 0.000 claims description 4
- JMTVQKMGWVDRNW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(2-hydroxyethyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCO)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 JMTVQKMGWVDRNW-UHFFFAOYSA-N 0.000 claims description 4
- CDDAHMMJPVSGEG-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(3-hydroxypropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCO)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 CDDAHMMJPVSGEG-UHFFFAOYSA-N 0.000 claims description 4
- GQLVXOANBOXIQA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-ethylbenzamide Chemical compound CCC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 GQLVXOANBOXIQA-UHFFFAOYSA-N 0.000 claims description 4
- LCBXHJUUUSMVQJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-methylbenzamide Chemical compound CC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 LCBXHJUUUSMVQJ-UHFFFAOYSA-N 0.000 claims description 4
- QXMRUZQGRPKZTN-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-ethylbenzamide Chemical compound CCC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 QXMRUZQGRPKZTN-UHFFFAOYSA-N 0.000 claims description 4
- BUMIHSDPFQCQPU-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 BUMIHSDPFQCQPU-UHFFFAOYSA-N 0.000 claims description 4
- WSGGDYOQRXZPHK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methylbenzamide Chemical compound CC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 WSGGDYOQRXZPHK-UHFFFAOYSA-N 0.000 claims description 4
- WVIKSKULBURUSG-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC(C(=C1)OC)=CC=C1C(=O)NC1CCOCC1 WVIKSKULBURUSG-UHFFFAOYSA-N 0.000 claims description 4
- WOXAQOYAOVFVAO-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCN(C)CC1 WOXAQOYAOVFVAO-UHFFFAOYSA-N 0.000 claims description 4
- YVEXJBKEHVYNBU-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCOCC1 YVEXJBKEHVYNBU-UHFFFAOYSA-N 0.000 claims description 4
- AOPLBXJWRHSSBY-UHFFFAOYSA-N 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]-3-methoxypiperidine-1-carboxylic acid Chemical compound COC1CN(C(O)=O)CCC1NC(=O)C(C=C1OC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 AOPLBXJWRHSSBY-UHFFFAOYSA-N 0.000 claims description 4
- DNKMRTCAQIWEMH-UAPYVXQJSA-N COc1cc(ccc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1)C(=O)N[C@H]1CC[C@H](O)CC1 Chemical compound COc1cc(ccc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1)C(=O)N[C@H]1CC[C@H](O)CC1 DNKMRTCAQIWEMH-UAPYVXQJSA-N 0.000 claims description 4
- KJJGHYCAQGXSND-UHFFFAOYSA-N benzyl 3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]-4-methoxypiperidine-1-carboxylate Chemical compound COC1CCN(C(=O)OCC=2C=CC=CC=2)CC1NC(=O)C(C=C1OC)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 KJJGHYCAQGXSND-UHFFFAOYSA-N 0.000 claims description 4
- PHYNULCBHHKXNF-UHFFFAOYSA-N benzyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]-3-hydroxypiperidine-1-carboxylate Chemical compound COC1=CC(C(=O)NC2C(CN(CC2)C(=O)OCC=2C=CC=CC=2)O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 PHYNULCBHHKXNF-UHFFFAOYSA-N 0.000 claims description 4
- XCAYLNUEFMJDPI-UHFFFAOYSA-N benzyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]-3-methoxypiperidine-1-carboxylate Chemical compound COC1CN(C(=O)OCC=2C=CC=CC=2)CCC1NC(=O)C(C=C1OC)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 XCAYLNUEFMJDPI-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- UKNAHZQUOVKSEY-UHFFFAOYSA-N n-(2-aminoethyl)-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 UKNAHZQUOVKSEY-UHFFFAOYSA-N 0.000 claims description 4
- LNRXIIDKFKDPDK-UHFFFAOYSA-N n-(3-aminopropyl)-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 LNRXIIDKFKDPDK-UHFFFAOYSA-N 0.000 claims description 4
- UTKYNIJOYJVVCV-UHFFFAOYSA-N tert-butyl 4-[3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]-2-hydroxypropyl]piperazine-1-carboxylate Chemical compound COC1=CC(C(=O)NCC(O)CN2CCN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 UTKYNIJOYJVVCV-UHFFFAOYSA-N 0.000 claims description 4
- ZXJQPLDVYSFMMO-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxybenzoyl]amino]piperidine-1-carboxylate Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 ZXJQPLDVYSFMMO-UHFFFAOYSA-N 0.000 claims description 4
- JICWZVNOOVUFPQ-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-(trifluoromethyl)benzoyl]amino]piperidine-1-carboxylate Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)C(F)(F)F)=CC=C1C(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 JICWZVNOOVUFPQ-UHFFFAOYSA-N 0.000 claims description 4
- XKMOEYVYJAKVCC-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethylbenzoyl]amino]piperidine-1-carboxylate Chemical compound CCC1=CC(C(=O)NC2CCN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 XKMOEYVYJAKVCC-UHFFFAOYSA-N 0.000 claims description 4
- RLJXSWWPBDQRQC-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methylbenzoyl]amino]piperidine-1-carboxylate Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)C)=CC=C1C(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 RLJXSWWPBDQRQC-UHFFFAOYSA-N 0.000 claims description 4
- YRJDTCLZCJQGRW-UHFFFAOYSA-N 4-[(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCC1 YRJDTCLZCJQGRW-UHFFFAOYSA-N 0.000 claims description 3
- RYLGNUNRJIFJKD-UHFFFAOYSA-N 4-[(9-cyclopentyl-5-ethyl-7,7-difluoro-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CC)C2=CN=C1NC1=CC=C(C(N)=O)C=C1 RYLGNUNRJIFJKD-UHFFFAOYSA-N 0.000 claims description 3
- GCUSJAKGEHXMMP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC(C(=O)N(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 GCUSJAKGEHXMMP-UHFFFAOYSA-N 0.000 claims description 3
- QAEBWIGYZGSZLV-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1,2,2,6,6-pentamethylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CC(C)(C)N(C)C(C)(C)C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 QAEBWIGYZGSZLV-UHFFFAOYSA-N 0.000 claims description 3
- HNYYPGGUOWXBRZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2,2,2-trifluoroethyl)benzamide Chemical compound COC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 HNYYPGGUOWXBRZ-UHFFFAOYSA-N 0.000 claims description 3
- GPCOICHTEDRQPJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2-morpholin-4-ylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCN2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 GPCOICHTEDRQPJ-UHFFFAOYSA-N 0.000 claims description 3
- MUYSTFCIYMONGL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2-piperazin-1-ylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCN2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 MUYSTFCIYMONGL-UHFFFAOYSA-N 0.000 claims description 3
- VNJSZNVUAZYRHM-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2-pyridin-2-ylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCC=2N=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 VNJSZNVUAZYRHM-UHFFFAOYSA-N 0.000 claims description 3
- HNGGTOIHLQKNLD-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(3-methoxypropyl)benzamide Chemical compound COC1=CC(C(=O)NCCCOC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 HNGGTOIHLQKNLD-UHFFFAOYSA-N 0.000 claims description 3
- IYEVKFRISSVCQZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(3-morpholin-4-ylpropyl)benzamide Chemical compound COC1=CC(C(=O)NCCCN2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 IYEVKFRISSVCQZ-UHFFFAOYSA-N 0.000 claims description 3
- CCTSONUJHJYHOL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(3-piperazin-1-ylpropyl)benzamide Chemical compound COC1=CC(C(=O)NCCCN2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 CCTSONUJHJYHOL-UHFFFAOYSA-N 0.000 claims description 3
- BVGRFOSUDOWGPJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(3-piperidin-1-ylpropyl)benzamide Chemical compound COC1=CC(C(=O)NCCCN2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 BVGRFOSUDOWGPJ-UHFFFAOYSA-N 0.000 claims description 3
- LMVXOIOZFWFVQH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(3-pyrrolidin-1-ylpropyl)benzamide Chemical compound COC1=CC(C(=O)NCCCN2CCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 LMVXOIOZFWFVQH-UHFFFAOYSA-N 0.000 claims description 3
- INRRBJHFKZXWEP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CC3CCC(N3C)C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 INRRBJHFKZXWEP-UHFFFAOYSA-N 0.000 claims description 3
- NWBQJXADKGIORI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(thiophen-3-ylmethyl)benzamide Chemical compound COC1=CC(C(=O)NCC2=CSC=C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 NWBQJXADKGIORI-UHFFFAOYSA-N 0.000 claims description 3
- HNWQTQZVTFKAGZ-MRXNPFEDSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[(4r)-2-oxopiperidin-4-yl]benzamide Chemical compound COC1=CC(C(=O)N[C@H]2CC(=O)NCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 HNWQTQZVTFKAGZ-MRXNPFEDSA-N 0.000 claims description 3
- HLCDTULFFZETLA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]benzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC(F)(F)F)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 HLCDTULFFZETLA-UHFFFAOYSA-N 0.000 claims description 3
- LVBNGIACKIUHCF-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[2-(4-methylpiperazin-1-yl)ethyl]benzamide Chemical compound COC1=CC(C(=O)NCCN2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 LVBNGIACKIUHCF-UHFFFAOYSA-N 0.000 claims description 3
- YSHXGRIXSBLABD-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[3-(4-methylpiperazin-1-yl)propyl]benzamide Chemical compound COC1=CC(C(=O)NCCCN2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 YSHXGRIXSBLABD-UHFFFAOYSA-N 0.000 claims description 3
- GAOBDFYSUUSEPG-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-[3-(propan-2-ylamino)propyl]benzamide Chemical compound COC1=CC(C(=O)NCCCNC(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 GAOBDFYSUUSEPG-UHFFFAOYSA-N 0.000 claims description 3
- BTQNGTAMCLWLOP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 BTQNGTAMCLWLOP-UHFFFAOYSA-N 0.000 claims description 3
- KZSITJNQLRUINH-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-propan-2-ylbenzamide Chemical compound COC1=CC(C(=O)NC(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 KZSITJNQLRUINH-UHFFFAOYSA-N 0.000 claims description 3
- AVKAQJDXBSJSPO-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-pyridin-3-ylbenzamide Chemical compound COC1=CC(C(=O)NC=2C=NC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 AVKAQJDXBSJSPO-UHFFFAOYSA-N 0.000 claims description 3
- ASFPJTHORZNERZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-pyridin-4-ylbenzamide Chemical compound COC1=CC(C(=O)NC=2C=CN=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 ASFPJTHORZNERZ-UHFFFAOYSA-N 0.000 claims description 3
- VLZNQQJFEDMMIZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 VLZNQQJFEDMMIZ-UHFFFAOYSA-N 0.000 claims description 3
- XPKIADKBUUPSBL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(2-hydroxy-3-piperazin-1-ylpropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC(O)CN2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 XPKIADKBUUPSBL-UHFFFAOYSA-N 0.000 claims description 3
- CRQJRUCZEVKRND-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(furan-3-ylmethyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC2=COC=C2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 CRQJRUCZEVKRND-UHFFFAOYSA-N 0.000 claims description 3
- KIXZXNODEAFUAR-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[(3,5-dichlorophenyl)methyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC=2C=C(Cl)C=C(Cl)C=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 KIXZXNODEAFUAR-UHFFFAOYSA-N 0.000 claims description 3
- ZYAZPEKBRUKQJS-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCC=2C3=CC=CC=C3NC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 ZYAZPEKBRUKQJS-UHFFFAOYSA-N 0.000 claims description 3
- NUUFTAWVCPDSTE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 NUUFTAWVCPDSTE-UHFFFAOYSA-N 0.000 claims description 3
- OZTBNNQBOHWSGL-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-cyclopropyl-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 OZTBNNQBOHWSGL-UHFFFAOYSA-N 0.000 claims description 3
- VBFQMIXSLOAOFT-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1NC(=O)C(F)(F)CN2C1CCCC1 VBFQMIXSLOAOFT-UHFFFAOYSA-N 0.000 claims description 3
- WEFHVUWCANKDBA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1NC(=O)C(F)(F)CN2C1CCCC1 WEFHVUWCANKDBA-UHFFFAOYSA-N 0.000 claims description 3
- FVTQIVPBYWNZJV-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 FVTQIVPBYWNZJV-UHFFFAOYSA-N 0.000 claims description 3
- OLCDDJZSGLELBF-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 OLCDDJZSGLELBF-UHFFFAOYSA-N 0.000 claims description 3
- GDPYAUCFLCWOIV-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 GDPYAUCFLCWOIV-UHFFFAOYSA-N 0.000 claims description 3
- HJGMRAKQWLKWMH-UHFFFAOYSA-N 8-methyl-8-azabicyclo[3.2.1]octan-3-amine Chemical group C1C(N)CC2CCC1N2C HJGMRAKQWLKWMH-UHFFFAOYSA-N 0.000 claims description 3
- WSPVFFIWYNLVAR-UHFFFAOYSA-N 9-cyclopentyl-7,7-difluoro-2-[2-methoxy-4-(4-methylpiperazine-1-carbonyl)anilino]-5-methyl-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound COC1=CC(C(=O)N2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 WSPVFFIWYNLVAR-UHFFFAOYSA-N 0.000 claims description 3
- FJUIIVZFSXTVTL-UHFFFAOYSA-N 9-cyclopentyl-7,7-difluoro-2-[2-methoxy-4-(morpholine-4-carbonyl)anilino]-5-methyl-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound COC1=CC(C(=O)N2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 FJUIIVZFSXTVTL-UHFFFAOYSA-N 0.000 claims description 3
- YGIQYQOTXRBFNT-UHFFFAOYSA-N 9-cyclopentyl-7,7-difluoro-2-[2-methoxy-4-(piperidine-1-carbonyl)anilino]-5-methyl-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound COC1=CC(C(=O)N2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 YGIQYQOTXRBFNT-UHFFFAOYSA-N 0.000 claims description 3
- BXQWIISLBIAIBL-UHFFFAOYSA-N COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 BXQWIISLBIAIBL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- GQQIMHYTWZYXRD-UHFFFAOYSA-N n-(2-anilinoethyl)-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCNC=2C=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 GQQIMHYTWZYXRD-UHFFFAOYSA-N 0.000 claims description 3
- YORMABKAWXREKJ-MSOLQXFVSA-N n-[(1s,2r)-2-carbamoylcyclopentyl]-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)N[C@@H]2[C@@H](CCC2)C(N)=O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 YORMABKAWXREKJ-MSOLQXFVSA-N 0.000 claims description 3
- PMSBBZYMFIXRRY-HSZRJFAPSA-N n-[(3r)-1-benzylpyrrolidin-3-yl]-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)N[C@H]2CN(CC=3C=CC=CC=3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 PMSBBZYMFIXRRY-HSZRJFAPSA-N 0.000 claims description 3
- PMSBBZYMFIXRRY-QHCPKHFHSA-N n-[(3s)-1-benzylpyrrolidin-3-yl]-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)N[C@@H]2CN(CC=3C=CC=CC=3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 PMSBBZYMFIXRRY-QHCPKHFHSA-N 0.000 claims description 3
- LTXYXSPAWRYBHE-UHFFFAOYSA-N n-[1-(2-amino-2-methylpropanoyl)piperidin-4-yl]-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C(=O)C(C)(C)N)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 LTXYXSPAWRYBHE-UHFFFAOYSA-N 0.000 claims description 3
- DFZLKACBKLZYPV-UHFFFAOYSA-N n-[2-(1,3-benzodioxol-5-yl)ethyl]-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCC=2C=C3OCOC3=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 DFZLKACBKLZYPV-UHFFFAOYSA-N 0.000 claims description 3
- JRQQKDFKPKOJMQ-UHFFFAOYSA-N n-benzyl-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC=2C=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 JRQQKDFKPKOJMQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- IVLIBVDZIYFXBZ-UHFFFAOYSA-N 1-(cyclopropylmethyl)piperazine Chemical group C1CNCCN1CC1CC1 IVLIBVDZIYFXBZ-UHFFFAOYSA-N 0.000 claims description 2
- CLTNVISMFUXTBB-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2-methoxyethyl)benzamide Chemical compound COC1=CC(C(=O)NCCOC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 CLTNVISMFUXTBB-UHFFFAOYSA-N 0.000 claims description 2
- SGURCXCFSYTOBV-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-ethoxybenzamide Chemical compound CCOC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 SGURCXCFSYTOBV-UHFFFAOYSA-N 0.000 claims description 2
- PLUVZWFMFVKRHA-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-ethoxybenzamide Chemical compound CCOC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 PLUVZWFMFVKRHA-UHFFFAOYSA-N 0.000 claims description 2
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims description 2
- 125000001188 haloalkyl group Chemical group 0.000 claims description 2
- QKTDZSUFSULVBU-UHFFFAOYSA-N n-(cyclohexylmethyl)-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 QKTDZSUFSULVBU-UHFFFAOYSA-N 0.000 claims description 2
- CYPURHFPZAURSP-UHFFFAOYSA-N n-cyclohexyl-4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 CYPURHFPZAURSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims 11
- PKZWKPAABMRORY-UHFFFAOYSA-N 4-[(7,7-dichloro-9-cyclopentyl-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(Cl)(Cl)CN2C1CCCC1 PKZWKPAABMRORY-UHFFFAOYSA-N 0.000 claims 1
- CUGXNMGSBCPUMK-UHFFFAOYSA-N 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C=1C=C(NC=2N=C3N(C(C)C)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C)CC1 CUGXNMGSBCPUMK-UHFFFAOYSA-N 0.000 claims 1
- ARNDJWGIBIQISZ-UHFFFAOYSA-N 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound C=1C=C(NC=2N=C3N(C(C)C)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCOCC1 ARNDJWGIBIQISZ-UHFFFAOYSA-N 0.000 claims 1
- HUPWVZNKIAVJMW-UHFFFAOYSA-N 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C(C)C)C2=N1 HUPWVZNKIAVJMW-UHFFFAOYSA-N 0.000 claims 1
- JWCXYAVDRNDFPO-UHFFFAOYSA-N 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C(C)C)C2=N1 JWCXYAVDRNDFPO-UHFFFAOYSA-N 0.000 claims 1
- QUXFDKQTHXTQKE-UHFFFAOYSA-N 4-[(7,7-difluoro-5-methyl-6-oxo-9-propan-2-yl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C(C)C)C2=N1 QUXFDKQTHXTQKE-UHFFFAOYSA-N 0.000 claims 1
- FGRHPASIBCUARJ-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 FGRHPASIBCUARJ-UHFFFAOYSA-N 0.000 claims 1
- FBTDYGMLBQDGIM-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-methylsulfonylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)S(C)(=O)=O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 FBTDYGMLBQDGIM-UHFFFAOYSA-N 0.000 claims 1
- ZGWQLOBGRDTDNI-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 ZGWQLOBGRDTDNI-UHFFFAOYSA-N 0.000 claims 1
- DNJPAXPYOSESEY-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 DNJPAXPYOSESEY-UHFFFAOYSA-N 0.000 claims 1
- SUPNECRXMVETSH-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-piperidin-4-ylbenzamide Chemical compound COC1=CC(C(=O)NC2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 SUPNECRXMVETSH-UHFFFAOYSA-N 0.000 claims 1
- AGLAFVGBYPTFSF-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 AGLAFVGBYPTFSF-UHFFFAOYSA-N 0.000 claims 1
- ZJJQPFRCTQEAIS-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 ZJJQPFRCTQEAIS-UHFFFAOYSA-N 0.000 claims 1
- HRGFYVLLNOAVFY-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-3-methoxybenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1OC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 HRGFYVLLNOAVFY-UHFFFAOYSA-N 0.000 claims 1
- YLADGQXKSNCGKS-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)benzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 YLADGQXKSNCGKS-UHFFFAOYSA-N 0.000 claims 1
- GCXJBVYDGVPBCS-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 GCXJBVYDGVPBCS-UHFFFAOYSA-N 0.000 claims 1
- PXLYQMIBLQYWRP-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCOCC1 PXLYQMIBLQYWRP-UHFFFAOYSA-N 0.000 claims 1
- RKYMNZOWUOTBEK-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[1-(2,2-difluoroethyl)piperidin-4-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC(F)F)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 RKYMNZOWUOTBEK-UHFFFAOYSA-N 0.000 claims 1
- FDEAOXUCYSKSBH-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[1-(2-hydroxyethyl)piperidin-4-yl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC2CCN(CCO)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 FDEAOXUCYSKSBH-UHFFFAOYSA-N 0.000 claims 1
- ZXIMKXCWMIZHHX-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 ZXIMKXCWMIZHHX-UHFFFAOYSA-N 0.000 claims 1
- XBGZEXDIOCODLL-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]benzamide Chemical compound C1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 XBGZEXDIOCODLL-UHFFFAOYSA-N 0.000 claims 1
- SDGSPTXHFKBIOR-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 SDGSPTXHFKBIOR-UHFFFAOYSA-N 0.000 claims 1
- RKVOJGVAISIHDB-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]benzamide Chemical compound C1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 RKVOJGVAISIHDB-UHFFFAOYSA-N 0.000 claims 1
- SFEDOHDRAWCOEB-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCCC3)C2=N1 SFEDOHDRAWCOEB-UHFFFAOYSA-N 0.000 claims 1
- GKPMVOVWWOBSJA-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-piperidin-4-ylbenzamide Chemical compound N1=C2N(C3CCCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCNCC1 GKPMVOVWWOBSJA-UHFFFAOYSA-N 0.000 claims 1
- OJNVHXMLCTZNGV-UHFFFAOYSA-N 4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzamide Chemical compound N1=C2N(C3CCCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(N)=O)C=C1 OJNVHXMLCTZNGV-UHFFFAOYSA-N 0.000 claims 1
- SKEBOOPGDXDDDN-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluoro-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C(=C1)F)=CC(F)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 SKEBOOPGDXDDDN-UHFFFAOYSA-N 0.000 claims 1
- JTFLRWFVYXSAOS-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluoro-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)F)=CC(F)=C1C(=O)NC1CCOCC1 JTFLRWFVYXSAOS-UHFFFAOYSA-N 0.000 claims 1
- VDWGTPLOWNWQGN-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluoro-n-methylbenzamide Chemical compound C1=C(F)C(C(=O)NC)=CC(F)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 VDWGTPLOWNWQGN-UHFFFAOYSA-N 0.000 claims 1
- JHDSUJPDQFZEKI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluoro-n-piperidin-4-ylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)F)=CC(F)=C1C(=O)NC1CCNCC1 JHDSUJPDQFZEKI-UHFFFAOYSA-N 0.000 claims 1
- JXKCARWDXKMBGI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluorobenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC(F)=C(C(N)=O)C=C1F JXKCARWDXKMBGI-UHFFFAOYSA-N 0.000 claims 1
- LUYHDUGQYPBZGP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluorobenzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC(F)=C(C(O)=O)C=C1F LUYHDUGQYPBZGP-UHFFFAOYSA-N 0.000 claims 1
- FXGCQVSPPRYQAM-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxy-n-methylbenzamide Chemical compound CCOC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 FXGCQVSPPRYQAM-UHFFFAOYSA-N 0.000 claims 1
- HLUONFKZMLAYCY-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxy-n-piperidin-4-ylbenzamide Chemical compound CCOC1=CC(C(=O)NC2CCNCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 HLUONFKZMLAYCY-UHFFFAOYSA-N 0.000 claims 1
- JCNZRYVEUXJGCI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxybenzamide Chemical compound CCOC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 JCNZRYVEUXJGCI-UHFFFAOYSA-N 0.000 claims 1
- WZBUBWITXSQWLR-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluoro-n-(oxan-4-yl)benzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)F)=CC=C1C(=O)NC1CCOCC1 WZBUBWITXSQWLR-UHFFFAOYSA-N 0.000 claims 1
- DLSFXYQPELZWEZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluoro-n-methylbenzamide Chemical compound FC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 DLSFXYQPELZWEZ-UHFFFAOYSA-N 0.000 claims 1
- YWWBXCRLCNKINB-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluoro-n-piperidin-4-ylbenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)F)=CC=C1C(=O)NC1CCNCC1 YWWBXCRLCNKINB-UHFFFAOYSA-N 0.000 claims 1
- MAKAIJXKQUTJTJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluorobenzamide Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC1=CC=C(C(N)=O)C=C1F MAKAIJXKQUTJTJ-UHFFFAOYSA-N 0.000 claims 1
- NPPHMOYTHILRBX-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-2,5-difluorobenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C(=C1)F)=CC(F)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 NPPHMOYTHILRBX-UHFFFAOYSA-N 0.000 claims 1
- ZOJWJHKYZDEFMQ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-3-fluorobenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C=C1F)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 ZOJWJHKYZDEFMQ-UHFFFAOYSA-N 0.000 claims 1
- KLODPNJUOYRALG-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[2-(dimethylamino)ethyl]-2,5-difluorobenzamide Chemical compound C1=C(F)C(C(=O)NCCN(C)C)=CC(F)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 KLODPNJUOYRALG-UHFFFAOYSA-N 0.000 claims 1
- SAZVLMGBIDCDFM-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-2,5-difluorobenzamide Chemical compound C1=C(F)C(C(=O)NCCCN(C)C)=CC(F)=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 SAZVLMGBIDCDFM-UHFFFAOYSA-N 0.000 claims 1
- NSPNACLUIZEWKW-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(dimethylamino)propyl]-3-fluorobenzamide Chemical compound FC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 NSPNACLUIZEWKW-UHFFFAOYSA-N 0.000 claims 1
- PNFWQWFXIKTIPN-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,3-difluoro-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C(=C1F)F)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 PNFWQWFXIKTIPN-UHFFFAOYSA-N 0.000 claims 1
- IKZDOPRZUPWTHM-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,3-difluoro-n-methylbenzamide Chemical compound FC1=C(F)C(C(=O)NC)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 IKZDOPRZUPWTHM-UHFFFAOYSA-N 0.000 claims 1
- KOXGESDGCSTWOK-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5,8-dihydropyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-ethylpiperidin-4-yl)-2,3-difluorobenzamide Chemical compound C1CN(CC)CCC1NC(=O)C(C(=C1F)F)=CC=C1NC1=NC=C(NC(=O)C(F)(F)CN2C3CCCC3)C2=N1 KOXGESDGCSTWOK-UHFFFAOYSA-N 0.000 claims 1
- FZORPKVINHUJOU-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenoxyethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCOC1=CC=CC=C1 FZORPKVINHUJOU-UHFFFAOYSA-N 0.000 claims 1
- XJDFPABNFMGUQZ-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCC1=CC=CC=C1 XJDFPABNFMGUQZ-UHFFFAOYSA-N 0.000 claims 1
- TUQMYIJNTSGUGF-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCC1=CC=CC=C1 TUQMYIJNTSGUGF-UHFFFAOYSA-N 0.000 claims 1
- PSUBGYPXALNCMG-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3C=CC=CC=3)C2=N1 PSUBGYPXALNCMG-UHFFFAOYSA-N 0.000 claims 1
- XSDGPZQANIZACZ-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3C=CC=CC=3)C2=N1 XSDGPZQANIZACZ-UHFFFAOYSA-N 0.000 claims 1
- PCPAXXKTKQUPHR-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3C=CC=CC=3)C2=N1 PCPAXXKTKQUPHR-UHFFFAOYSA-N 0.000 claims 1
- NGAFYUZTCNBCGI-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-phenylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3C=CC=CC=3)C2=N1 NGAFYUZTCNBCGI-UHFFFAOYSA-N 0.000 claims 1
- KVBACVCSBJSAER-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-thiophen-2-ylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCC1=CC=CS1 KVBACVCSBJSAER-UHFFFAOYSA-N 0.000 claims 1
- DGGHCJPFKMNPAU-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-thiophen-2-ylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCC1=CC=CS1 DGGHCJPFKMNPAU-UHFFFAOYSA-N 0.000 claims 1
- JSFTXPUPTJTYTB-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-thiophen-2-ylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3SC=CC=3)C2=N1 JSFTXPUPTJTYTB-UHFFFAOYSA-N 0.000 claims 1
- KMWJCCMWYIKRNP-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-thiophen-2-ylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3SC=CC=3)C2=N1 KMWJCCMWYIKRNP-UHFFFAOYSA-N 0.000 claims 1
- MNHDFLRMCRZSOS-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(2-thiophen-2-ylethyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCC=3SC=CC=3)C2=N1 MNHDFLRMCRZSOS-UHFFFAOYSA-N 0.000 claims 1
- QIMBUKMFWMBEHR-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(3-phenylpropyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(C)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCCC1=CC=CC=C1 QIMBUKMFWMBEHR-UHFFFAOYSA-N 0.000 claims 1
- PHXLWWFFQDNSSE-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(3-phenylpropyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(oxan-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCOCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2CCCC1=CC=CC=C1 PHXLWWFFQDNSSE-UHFFFAOYSA-N 0.000 claims 1
- DMMUXYAYHYDDLV-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(3-phenylpropyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCCC=3C=CC=CC=3)C2=N1 DMMUXYAYHYDDLV-UHFFFAOYSA-N 0.000 claims 1
- UXZZINQYOKUPEO-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(3-phenylpropyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCCC=3C=CC=CC=3)C2=N1 UXZZINQYOKUPEO-UHFFFAOYSA-N 0.000 claims 1
- XXIJBRADQSRHDK-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(3-phenylpropyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCCC=3C=CC=CC=3)C2=N1 XXIJBRADQSRHDK-UHFFFAOYSA-N 0.000 claims 1
- GHTYTXXJOCCCQB-UHFFFAOYSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-(3-phenylpropyl)-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2CCCC=3C=CC=CC=3)C2=N1 GHTYTXXJOCCCQB-UHFFFAOYSA-N 0.000 claims 1
- AVYWETQIOGLARX-FUHWJXTLSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-[(1r,2s)-2-phenylcyclopropyl]-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2[C@H]3[C@@H](C3)C=3C=CC=CC=3)C2=N1 AVYWETQIOGLARX-FUHWJXTLSA-N 0.000 claims 1
- IXGLPNQCLBXUHO-FUHWJXTLSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-[(1r,2s)-2-phenylcyclopropyl]-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2[C@H]3[C@@H](C3)C=3C=CC=CC=3)C2=N1 IXGLPNQCLBXUHO-FUHWJXTLSA-N 0.000 claims 1
- IWZPVFATWJHPPC-JTHBVZDNSA-N 4-[[7,7-difluoro-5-methyl-6-oxo-9-[(1r,2s)-2-phenylcyclopropyl]-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2[C@H]3[C@@H](C3)C=3C=CC=CC=3)C2=N1 IWZPVFATWJHPPC-JTHBVZDNSA-N 0.000 claims 1
- GLTMSDBAMFENHK-UHFFFAOYSA-N 4-[[7,7-difluoro-9-[(4-methoxyphenyl)methyl]-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1=CC(OC)=CC=C1CN1C2=NC(NC=3C(=CC(=CC=3)C(=O)NC3CCN(C)CC3)OC)=NC=C2N(C)C(=O)C(F)(F)C1 GLTMSDBAMFENHK-UHFFFAOYSA-N 0.000 claims 1
- USPFWUYOJAKGOU-PLQXJYEYSA-N C1CN([C@@H]2CC[C@@H](CC2)NC(=O)C=2C=C(C(=CC=2)NC=2N=C3N(C(C)C)CC(F)(F)C(=O)N(C)C3=CN=2)OC)CCN1CC1CC1 Chemical compound C1CN([C@@H]2CC[C@@H](CC2)NC(=O)C=2C=C(C(=CC=2)NC=2N=C3N(C(C)C)CC(F)(F)C(=O)N(C)C3=CN=2)OC)CCN1CC1CC1 USPFWUYOJAKGOU-PLQXJYEYSA-N 0.000 claims 1
- USPFWUYOJAKGOU-SOAUALDESA-N C1CN([C@H]2CC[C@@H](CC2)NC(=O)C=2C=C(C(=CC=2)NC=2N=C3N(C(C)C)CC(F)(F)C(=O)N(C)C3=CN=2)OC)CCN1CC1CC1 Chemical compound C1CN([C@H]2CC[C@@H](CC2)NC(=O)C=2C=C(C(=CC=2)NC=2N=C3N(C(C)C)CC(F)(F)C(=O)N(C)C3=CN=2)OC)CCN1CC1CC1 USPFWUYOJAKGOU-SOAUALDESA-N 0.000 claims 1
- FWZMTAVQGNDTNM-WMPKNSHKSA-N COC1=CC(C(=O)N[C@@H]2CC[C@@H](CC2)N2CCN(CC3CC3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 Chemical compound COC1=CC(C(=O)N[C@@H]2CC[C@@H](CC2)N2CCN(CC3CC3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 FWZMTAVQGNDTNM-WMPKNSHKSA-N 0.000 claims 1
- FWZMTAVQGNDTNM-DIVCQZSQSA-N COC1=CC(C(=O)N[C@@H]2CC[C@H](CC2)N2CCN(CC3CC3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 Chemical compound COC1=CC(C(=O)N[C@@H]2CC[C@H](CC2)N2CCN(CC3CC3)CC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 FWZMTAVQGNDTNM-DIVCQZSQSA-N 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- RUGAMBHGZUMJLN-UHFFFAOYSA-N methyl 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,3-difluorobenzoate Chemical compound FC1=C(F)C(C(=O)OC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 RUGAMBHGZUMJLN-UHFFFAOYSA-N 0.000 claims 1
- AROXHAPNPSUGBQ-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]piperidine-1-carboxylate Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCCC1 AROXHAPNPSUGBQ-UHFFFAOYSA-N 0.000 claims 1
- KOXKOVWXQAYMTM-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzoyl]amino]piperidine-1-carboxylate Chemical compound N1=C2N(C3CCCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C=C1)=CC=C1C(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 KOXKOVWXQAYMTM-UHFFFAOYSA-N 0.000 claims 1
- XJDKJDUJZXQWKV-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2,5-difluorobenzoyl]amino]piperidine-1-carboxylate Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)F)=CC(F)=C1C(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 XJDKJDUJZXQWKV-UHFFFAOYSA-N 0.000 claims 1
- WRBGYSDTDUHBSV-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-ethoxybenzoyl]amino]piperidine-1-carboxylate Chemical compound CCOC1=CC(C(=O)NC2CCN(CC2)C(=O)OC(C)(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 WRBGYSDTDUHBSV-UHFFFAOYSA-N 0.000 claims 1
- KIVOHJZTNOGQGE-UHFFFAOYSA-N tert-butyl 4-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluorobenzoyl]amino]piperidine-1-carboxylate Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(C)C2=CN=C1NC(C(=C1)F)=CC=C1C(=O)NC1CCN(C(=O)OC(C)(C)C)CC1 KIVOHJZTNOGQGE-UHFFFAOYSA-N 0.000 claims 1
- 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 abstract description 13
- 108010056274 polo-like kinase 1 Proteins 0.000 abstract description 12
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 230000001629 suppression Effects 0.000 abstract description 4
- 239000003112 inhibitor Substances 0.000 abstract description 3
- 230000002062 proliferating effect Effects 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 588
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 466
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 393
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 228
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 218
- 238000010898 silica gel chromatography Methods 0.000 description 216
- 239000012267 brine Substances 0.000 description 185
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 185
- 239000007787 solid Substances 0.000 description 185
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 168
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 162
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 120
- DQJHTCZROXSXEZ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 DQJHTCZROXSXEZ-UHFFFAOYSA-N 0.000 description 103
- 229920006395 saturated elastomer Polymers 0.000 description 102
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 101
- 239000012044 organic layer Substances 0.000 description 97
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 87
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 87
- 239000000243 solution Substances 0.000 description 87
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 84
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 84
- 235000017557 sodium bicarbonate Nutrition 0.000 description 84
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 83
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 82
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 82
- 239000000284 extract Substances 0.000 description 65
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 61
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 61
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 61
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 56
- 238000001914 filtration Methods 0.000 description 53
- 239000012071 phase Substances 0.000 description 52
- 239000011541 reaction mixture Substances 0.000 description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 48
- 238000003756 stirring Methods 0.000 description 47
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 45
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 44
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 41
- 239000008346 aqueous phase Substances 0.000 description 38
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- JXYPNRIYAMXJSE-UHFFFAOYSA-N 1,4-diazepin-6-one Chemical compound O=C1C=NC=CN=C1 JXYPNRIYAMXJSE-UHFFFAOYSA-N 0.000 description 29
- 229910000029 sodium carbonate Inorganic materials 0.000 description 29
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 27
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 26
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 24
- 239000000706 filtrate Substances 0.000 description 24
- 239000005457 ice water Substances 0.000 description 23
- 235000019270 ammonium chloride Nutrition 0.000 description 22
- 239000010410 layer Substances 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 17
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 16
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- CVLAEJNQNKXNNN-UHFFFAOYSA-N diazepin-4-one Chemical compound O=C1C=CC=NN=C1 CVLAEJNQNKXNNN-UHFFFAOYSA-N 0.000 description 14
- 238000005406 washing Methods 0.000 description 14
- 125000004429 atom Chemical group 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- VNJOEUSYAMPBAK-UHFFFAOYSA-N 2-methylbenzenesulfonic acid;hydrate Chemical compound O.CC1=CC=CC=C1S(O)(=O)=O VNJOEUSYAMPBAK-UHFFFAOYSA-N 0.000 description 11
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 10
- AHVQYHFYQWKUKB-UHFFFAOYSA-N oxan-4-amine Chemical compound NC1CCOCC1 AHVQYHFYQWKUKB-UHFFFAOYSA-N 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 9
- CELPHAGZKFMOMR-UHFFFAOYSA-N azanium;dichloromethane;methanol;hydroxide Chemical compound [NH4+].[OH-].OC.ClCCl CELPHAGZKFMOMR-UHFFFAOYSA-N 0.000 description 9
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 9
- 239000012964 benzotriazole Substances 0.000 description 9
- 239000001110 calcium chloride Substances 0.000 description 9
- 229910001628 calcium chloride Inorganic materials 0.000 description 9
- ALOCUZOKRULSAA-UHFFFAOYSA-N 1-methylpiperidin-4-amine Chemical compound CN1CCC(N)CC1 ALOCUZOKRULSAA-UHFFFAOYSA-N 0.000 description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
- RDYSIKZETQMYPK-UHFFFAOYSA-N azanium;ethyl acetate;methanol;hydroxide Chemical compound N.O.OC.CCOC(C)=O RDYSIKZETQMYPK-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000012230 colorless oil Substances 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- IRSJDVYTJUCXRV-UHFFFAOYSA-N ethyl 2-bromo-2,2-difluoroacetate Chemical compound CCOC(=O)C(F)(F)Br IRSJDVYTJUCXRV-UHFFFAOYSA-N 0.000 description 8
- QUCPBKFOMWSJFG-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-7,7-difluoro-5,8-dihydropyrimido[4,5-b][1,4]diazepin-6-one Chemical compound C12=NC(Cl)=NC=C2NC(=O)C(F)(F)CN1C1CCCC1 QUCPBKFOMWSJFG-UHFFFAOYSA-N 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 7
- HYGWWEUPMDNJES-UHFFFAOYSA-N benzotriazol-1-yl 4-amino-3-methoxybenzoate Chemical compound C1=C(N)C(OC)=CC(C(=O)ON2C3=CC=CC=C3N=N2)=C1 HYGWWEUPMDNJES-UHFFFAOYSA-N 0.000 description 7
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 7
- 229910000024 caesium carbonate Inorganic materials 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 7
- XQSNXLDLKOJJOU-UHFFFAOYSA-N pyrimido[5,4-c]diazepin-3-one Chemical compound N1=NC(=O)C=CC2=NC=NC=C21 XQSNXLDLKOJJOU-UHFFFAOYSA-N 0.000 description 7
- LZRDHSFPLUWYAX-UHFFFAOYSA-N tert-butyl 4-aminopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(N)CC1 LZRDHSFPLUWYAX-UHFFFAOYSA-N 0.000 description 7
- UFETTXCVHFVMPU-UHFFFAOYSA-N 1-ethylpiperidin-4-amine Chemical compound CCN1CCC(N)CC1 UFETTXCVHFVMPU-UHFFFAOYSA-N 0.000 description 6
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 6
- QZMKHBQNIWNUPJ-UHFFFAOYSA-N acetonitrile;n,n-diethylethanamine;methanol Chemical compound OC.CC#N.CCN(CC)CC QZMKHBQNIWNUPJ-UHFFFAOYSA-N 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000003039 volatile agent Substances 0.000 description 6
- JNFGLYJROFAOQP-UHFFFAOYSA-N 4-amino-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1N JNFGLYJROFAOQP-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 229960004050 aminobenzoic acid Drugs 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- IYVLMMUENZSXFK-UHFFFAOYSA-N ethanol;hydrate;hydrochloride Chemical compound O.Cl.CCO IYVLMMUENZSXFK-UHFFFAOYSA-N 0.000 description 5
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- RCYQSXXMIWYNFY-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-fluoro-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1F)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 RCYQSXXMIWYNFY-UHFFFAOYSA-N 0.000 description 4
- VZCMIVYZRHZFIE-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-propan-2-ylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C(C)C)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 VZCMIVYZRHZFIE-UHFFFAOYSA-N 0.000 description 4
- SNIMMYAZEPPUPQ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-(1-methylpiperidin-4-yl)-3-(trifluoromethyl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C(C=C1C(F)(F)F)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 SNIMMYAZEPPUPQ-UHFFFAOYSA-N 0.000 description 4
- DLGOWFCNHXRLGX-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-6-oxo-5-propyl-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoic acid Chemical compound N1=C2N(C3CCCC3)CC(F)(F)C(=O)N(CCC)C2=CN=C1NC1=CC=C(C(O)=O)C=C1OC DLGOWFCNHXRLGX-UHFFFAOYSA-N 0.000 description 4
- NZWVECKCACDQSL-UHFFFAOYSA-N 4-amino-n-(oxan-4-yl)benzamide Chemical compound C1=CC(N)=CC=C1C(=O)NC1CCOCC1 NZWVECKCACDQSL-UHFFFAOYSA-N 0.000 description 4
- FEMQIZGAEIBWQU-UHFFFAOYSA-N 4-amino-n-[3-(dimethylamino)propyl]benzamide Chemical compound CN(C)CCCNC(=O)C1=CC=C(N)C=C1 FEMQIZGAEIBWQU-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 4
- PGFULZFLPKLOGP-UHFFFAOYSA-N n-(benzotriazol-1-ylmethyl)cyclopentanamine Chemical compound N1=NC2=CC=CC=C2N1CNC1CCCC1 PGFULZFLPKLOGP-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 3
- XBYFLVPPIOYEJF-UHFFFAOYSA-N 4-amino-3-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NC2CCN(C)CC2)=C1 XBYFLVPPIOYEJF-UHFFFAOYSA-N 0.000 description 3
- CRPNADDCMUASDT-UHFFFAOYSA-N 4-amino-n-(1-ethylpiperidin-4-yl)-3-methoxybenzamide Chemical compound C1CN(CC)CCC1NC(=O)C1=CC=C(N)C(OC)=C1 CRPNADDCMUASDT-UHFFFAOYSA-N 0.000 description 3
- VNOHEWUYHBJEMA-UHFFFAOYSA-N 4-amino-n-(1-methylpiperidin-4-yl)-3-(trifluoromethoxy)benzamide Chemical compound C1CN(C)CCC1NC(=O)C1=CC=C(N)C(OC(F)(F)F)=C1 VNOHEWUYHBJEMA-UHFFFAOYSA-N 0.000 description 3
- GJYKVMFSORVJSW-UHFFFAOYSA-N 4-amino-n-(1-methylpiperidin-4-yl)-3-propan-2-yloxybenzamide Chemical compound C1=C(N)C(OC(C)C)=CC(C(=O)NC2CCN(C)CC2)=C1 GJYKVMFSORVJSW-UHFFFAOYSA-N 0.000 description 3
- VAFDKVXEVKJBAY-UHFFFAOYSA-N 4-amino-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C1=CC=C(N)C=C1 VAFDKVXEVKJBAY-UHFFFAOYSA-N 0.000 description 3
- 101000582926 Dictyostelium discoideum Probable serine/threonine-protein kinase PLK Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229940123237 Taxane Drugs 0.000 description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
- 229940122803 Vinca alkaloid Drugs 0.000 description 3
- AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical compound OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 3
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- VQSNKVDLWIVTIF-UHFFFAOYSA-N ethyl 3-(cyclobutylamino)-2,2-difluoropropanoate Chemical compound CCOC(=O)C(F)(F)CNC1CCC1 VQSNKVDLWIVTIF-UHFFFAOYSA-N 0.000 description 3
- UXNKBIRHIGVUMN-UHFFFAOYSA-N ethyl 3-(cyclopentylamino)-2,2-difluoropropanoate Chemical compound CCOC(=O)C(F)(F)CNC1CCCC1 UXNKBIRHIGVUMN-UHFFFAOYSA-N 0.000 description 3
- ZKJVOFNXVHNODR-UHFFFAOYSA-N ethyl 3-[(2-chloro-5-nitropyrimidin-4-yl)-cyclopentylamino]-2,2-difluoropropanoate Chemical compound N=1C(Cl)=NC=C([N+]([O-])=O)C=1N(CC(F)(F)C(=O)OCC)C1CCCC1 ZKJVOFNXVHNODR-UHFFFAOYSA-N 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 150000002367 halogens Chemical group 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- FWSCIBSBSZSNGS-UHFFFAOYSA-N methyl 4-amino-2-fluoro-5-methoxybenzoate Chemical compound COC(=O)C1=CC(OC)=C(N)C=C1F FWSCIBSBSZSNGS-UHFFFAOYSA-N 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DPIDBFQLADISRN-IFMALSPDSA-N tert-butyl (3r,4r)-3-[[4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxybenzoyl]amino]-4-hydroxypyrrolidine-1-carboxylate Chemical compound COC1=CC(C(=O)N[C@H]2[C@@H](CN(C2)C(=O)OC(C)(C)C)O)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 DPIDBFQLADISRN-IFMALSPDSA-N 0.000 description 3
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 3
- CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- NJUKWAMNWWGBSF-DZGCQCFKSA-N (1r,2s)-n-(benzotriazol-1-ylmethyl)-2-phenylcyclopropan-1-amine Chemical compound C1([C@@H]2C[C@H]2NCN2C3=CC=CC=C3N=N2)=CC=CC=C1 NJUKWAMNWWGBSF-DZGCQCFKSA-N 0.000 description 2
- HOMHALWLEKDHPE-UHFFFAOYSA-N (2,2-dichloro-1-methoxyethenoxy)-trimethylsilane Chemical compound COC(=C(Cl)Cl)O[Si](C)(C)C HOMHALWLEKDHPE-UHFFFAOYSA-N 0.000 description 2
- NGXSWUFDCSEIOO-SCSAIBSYSA-N (3r)-pyrrolidin-3-amine Chemical compound N[C@@H]1CCNC1 NGXSWUFDCSEIOO-SCSAIBSYSA-N 0.000 description 2
- QADILAOBNCGRRK-UHFFFAOYSA-N 1-(3-methylsulfonylpropyl)piperidin-4-amine;dihydrochloride Chemical compound Cl.Cl.CS(=O)(=O)CCCN1CCC(N)CC1 QADILAOBNCGRRK-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- INUSQTPGSHFGHM-UHFFFAOYSA-N 2,4-dichloro-5-nitropyrimidine Chemical compound [O-][N+](=O)C1=CN=C(Cl)N=C1Cl INUSQTPGSHFGHM-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- GUQQUJIMGQWHTR-UHFFFAOYSA-N 2-chloro-9-cyclobutyl-7,7-difluoro-5,8-dihydropyrimido[4,5-b][1,4]diazepin-6-one Chemical compound C12=NC(Cl)=NC=C2NC(=O)C(F)(F)CN1C1CCC1 GUQQUJIMGQWHTR-UHFFFAOYSA-N 0.000 description 2
- FPKRPWFCTOXAGO-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-7,7-difluoro-5-(2,2,2-trifluoroethyl)-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound C1C(F)(F)C(=O)N(CC(F)(F)F)C2=CN=C(Cl)N=C2N1C1CCCC1 FPKRPWFCTOXAGO-UHFFFAOYSA-N 0.000 description 2
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 2
- UBKWUNBWODGGRI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-pyridin-2-ylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C=2N=CC=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 UBKWUNBWODGGRI-UHFFFAOYSA-N 0.000 description 2
- UEAPVUQHYNKYJN-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(1-pyridin-4-ylpiperidin-4-yl)benzamide Chemical compound COC1=CC(C(=O)NC2CCN(CC2)C=2C=CN=CC=2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 UEAPVUQHYNKYJN-UHFFFAOYSA-N 0.000 description 2
- FHYRMGNMJYUJBJ-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-n-(2-pyrrolidin-1-ylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCN2CCCC2)=CC=C1NC(N=C12)=NC=C1N(C)C(=O)C(F)(F)CN2C1CCCC1 FHYRMGNMJYUJBJ-UHFFFAOYSA-N 0.000 description 2
- XOKNBMJRPOLDMP-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-n-[3-(diethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(CC)CC)=CC=C1NC1=NC=C(N(C)C(=O)C(F)(F)CN2C3CCCC3)C2=N1 XOKNBMJRPOLDMP-UHFFFAOYSA-N 0.000 description 2
- ISCHUZLZPBODLL-UHFFFAOYSA-N 4-amino-3-chloro-n-(1-methylpiperidin-4-yl)benzamide Chemical compound C1CN(C)CCC1NC(=O)C1=CC=C(N)C(Cl)=C1 ISCHUZLZPBODLL-UHFFFAOYSA-N 0.000 description 2
- HOYOHEDWZMEKQW-UHFFFAOYSA-N 4-amino-3-methoxy-n-(1-methylsulfonylpiperidin-4-yl)benzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NC2CCN(CC2)S(C)(=O)=O)=C1 HOYOHEDWZMEKQW-UHFFFAOYSA-N 0.000 description 2
- WTLXHAGTFCEMAB-UHFFFAOYSA-N 4-amino-n-(1-ethylpiperidin-4-yl)benzamide Chemical compound C1CN(CC)CCC1NC(=O)C1=CC=C(N)C=C1 WTLXHAGTFCEMAB-UHFFFAOYSA-N 0.000 description 2
- BQLNWQFERPEHNT-UHFFFAOYSA-N 4-amino-n-[1-(2,2-difluoroethyl)piperidin-4-yl]-3-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NC2CCN(CC(F)F)CC2)=C1 BQLNWQFERPEHNT-UHFFFAOYSA-N 0.000 description 2
- RCMSMKIIFLZFBT-UHFFFAOYSA-N 4-amino-n-[1-(2-fluoroethyl)piperidin-4-yl]-3-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NC2CCN(CCF)CC2)=C1 RCMSMKIIFLZFBT-UHFFFAOYSA-N 0.000 description 2
- YSBHXSGJLRUFSU-UHFFFAOYSA-N 4-amino-n-[1-(2-hydroxyethyl)piperidin-4-yl]-3-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NC2CCN(CCO)CC2)=C1 YSBHXSGJLRUFSU-UHFFFAOYSA-N 0.000 description 2
- GFLWTVIVMBVDDZ-UHFFFAOYSA-N 4-amino-n-[2-(dimethylamino)ethyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN(C)C)=CC=C1N GFLWTVIVMBVDDZ-UHFFFAOYSA-N 0.000 description 2
- YHZSAVWVAXHDCW-UHFFFAOYSA-N 4-amino-n-[3-(dimethylamino)propyl]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCN(C)C)=CC=C1N YHZSAVWVAXHDCW-UHFFFAOYSA-N 0.000 description 2
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 2
- USHZRNJOYADWDS-UHFFFAOYSA-N 4-nitro-3-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC(C(O)=O)=CC=C1[N+]([O-])=O USHZRNJOYADWDS-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 101000729945 Homo sapiens Serine/threonine-protein kinase PLK2 Proteins 0.000 description 2
- 101000691614 Homo sapiens Serine/threonine-protein kinase PLK3 Proteins 0.000 description 2
- 101000582914 Homo sapiens Serine/threonine-protein kinase PLK4 Proteins 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102100031462 Serine/threonine-protein kinase PLK2 Human genes 0.000 description 2
- 102100026209 Serine/threonine-protein kinase PLK3 Human genes 0.000 description 2
- 102100030267 Serine/threonine-protein kinase PLK4 Human genes 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PRDBLLIPPDOICK-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]methanamine Chemical compound NCC1=CC=C(C(F)(F)F)C=C1 PRDBLLIPPDOICK-UHFFFAOYSA-N 0.000 description 2
- WXIONIWNXBAHRU-UHFFFAOYSA-N [dimethylamino(triazolo[4,5-b]pyridin-3-yloxy)methylidene]-dimethylazanium Chemical compound C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 WXIONIWNXBAHRU-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- GLLPINPRNBXUAG-UHFFFAOYSA-N benzotriazol-1-yl 4-aminobenzoate Chemical compound C1=CC(N)=CC=C1C(=O)ON1C2=CC=CC=C2N=N1 GLLPINPRNBXUAG-UHFFFAOYSA-N 0.000 description 2
- OMPQDSCQQOWFJN-CHWSQXEVSA-N benzyl (3r,4r)-4-amino-3-methoxypiperidine-1-carboxylate Chemical compound C1C[C@@H](N)[C@H](OC)CN1C(=O)OCC1=CC=CC=C1 OMPQDSCQQOWFJN-CHWSQXEVSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000025084 cell cycle arrest Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- KJOZJSGOIJQCGA-UHFFFAOYSA-N dichloromethane;2,2,2-trifluoroacetic acid Chemical compound ClCCl.OC(=O)C(F)(F)F KJOZJSGOIJQCGA-UHFFFAOYSA-N 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- OAKUSTACXHINKU-UHFFFAOYSA-N ethyl 2,2-difluoro-3-(2-phenylethylamino)propanoate Chemical compound CCOC(=O)C(F)(F)CNCCC1=CC=CC=C1 OAKUSTACXHINKU-UHFFFAOYSA-N 0.000 description 2
- HTKVNPPZURBEBA-UHFFFAOYSA-N ethyl 3-(cyclohexylamino)-2,2-difluoropropanoate Chemical group CCOC(=O)C(F)(F)CNC1CCCCC1 HTKVNPPZURBEBA-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- IORVHUKVQGLNLP-UHFFFAOYSA-N methyl 2,2-dichloro-3-(cyclopentylamino)propanoate Chemical compound COC(=O)C(Cl)(Cl)CNC1CCCC1 IORVHUKVQGLNLP-UHFFFAOYSA-N 0.000 description 2
- JMICQFYGYUNZNI-UHFFFAOYSA-N methyl 2-fluoro-5-methoxy-4-nitrobenzoate Chemical compound COC(=O)C1=CC(OC)=C([N+]([O-])=O)C=C1F JMICQFYGYUNZNI-UHFFFAOYSA-N 0.000 description 2
- GCJRDSAZLFQZHG-UHFFFAOYSA-N methyl 4-nitro-3-propan-2-yloxybenzoate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)C(OC(C)C)=C1 GCJRDSAZLFQZHG-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 230000006618 mitotic catastrophe Effects 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- IAVBZXQXYDTYEE-UHFFFAOYSA-N n-(1-methylpiperidin-4-yl)-4-nitro-3-propan-2-yloxybenzamide Chemical compound C1=C([N+]([O-])=O)C(OC(C)C)=CC(C(=O)NC2CCN(C)CC2)=C1 IAVBZXQXYDTYEE-UHFFFAOYSA-N 0.000 description 2
- GMQYZQIWPJCJOE-UHFFFAOYSA-N n-(benzotriazol-1-ylmethyl)-2-phenylethanamine Chemical compound N1=NC2=CC=CC=C2N1CNCCC1=CC=CC=C1 GMQYZQIWPJCJOE-UHFFFAOYSA-N 0.000 description 2
- GPAFWKQOMCOVRY-UHFFFAOYSA-N n-(benzotriazol-1-ylmethyl)-3-phenylpropan-1-amine Chemical compound N1=NC2=CC=CC=C2N1CNCCCC1=CC=CC=C1 GPAFWKQOMCOVRY-UHFFFAOYSA-N 0.000 description 2
- CEAJEILPXUOWLW-UHFFFAOYSA-N n-(benzotriazol-1-ylmethyl)cyclobutanamine Chemical compound N1=NC2=CC=CC=C2N1CNC1CCC1 CEAJEILPXUOWLW-UHFFFAOYSA-N 0.000 description 2
- FUROVGCSPHYQAH-UHFFFAOYSA-N n-(benzotriazol-1-ylmethyl)cyclohexanamine Chemical compound N1=NC2=CC=CC=C2N1CNC1CCCCC1 FUROVGCSPHYQAH-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- FOLRKRMAFDGZRR-UHFFFAOYSA-N tert-butyl 2,2-dichloroacetate Chemical compound CC(C)(C)OC(=O)C(Cl)Cl FOLRKRMAFDGZRR-UHFFFAOYSA-N 0.000 description 2
- AOCSUUGBCMTKJH-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCN AOCSUUGBCMTKJH-UHFFFAOYSA-N 0.000 description 2
- GZBNHUWODLVVSP-UHFFFAOYSA-N tert-butyl n-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC1CCN(CC(F)(F)F)CC1 GZBNHUWODLVVSP-UHFFFAOYSA-N 0.000 description 2
- KANGIZVPOGAZSP-UHFFFAOYSA-N tert-butyl n-[1-(2,2-difluoroethyl)piperidin-4-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC1CCN(CC(F)F)CC1 KANGIZVPOGAZSP-UHFFFAOYSA-N 0.000 description 2
- QKRGRVZMHABBTK-UHFFFAOYSA-N tert-butyl n-[1-(3-methylsulfonylpropyl)piperidin-4-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC1CCN(CCCS(C)(=O)=O)CC1 QKRGRVZMHABBTK-UHFFFAOYSA-N 0.000 description 2
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 2
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- AELCINSCMGFISI-DTWKUNHWSA-N (1R,2S)-tranylcypromine Chemical compound N[C@@H]1C[C@H]1C1=CC=CC=C1 AELCINSCMGFISI-DTWKUNHWSA-N 0.000 description 1
- FUGFTUCRJJFPES-UHNVWZDZSA-N (1r,2s)-2-aminocyclopentane-1-carboxamide Chemical compound N[C@H]1CCC[C@H]1C(N)=O FUGFTUCRJJFPES-UHNVWZDZSA-N 0.000 description 1
- ICIJWOWQUHHETJ-UHFFFAOYSA-N (3,5-dichlorophenyl)methanamine Chemical compound NCC1=CC(Cl)=CC(Cl)=C1 ICIJWOWQUHHETJ-UHFFFAOYSA-N 0.000 description 1
- YGNVYTSSBAFJCN-PHDIDXHHSA-N (3R,4R)-4-azido-3-methoxypiperidine-1-carboxylic acid Chemical compound N(=[N+]=[N-])[C@H]1[C@@H](CN(CC1)C(=O)O)OC YGNVYTSSBAFJCN-PHDIDXHHSA-N 0.000 description 1
- REUAXQZIRFXQML-ZETCQYMHSA-N (3r)-1-azabicyclo[2.2.2]octan-3-amine Chemical compound C1CC2[C@@H](N)CN1CC2 REUAXQZIRFXQML-ZETCQYMHSA-N 0.000 description 1
- HBVNLKQGRZPGRP-LLVKDONJSA-N (3r)-1-benzylpyrrolidin-3-amine Chemical compound C1[C@H](N)CCN1CC1=CC=CC=C1 HBVNLKQGRZPGRP-LLVKDONJSA-N 0.000 description 1
- ZCZJKVCIYONNJR-QWWZWVQMSA-N (3r,4r)-4-aminopyrrolidin-3-ol Chemical compound N[C@@H]1CNC[C@H]1O ZCZJKVCIYONNJR-QWWZWVQMSA-N 0.000 description 1
- REUAXQZIRFXQML-SSDOTTSWSA-N (3s)-1-azabicyclo[2.2.2]octan-3-amine Chemical compound C1CC2[C@H](N)CN1CC2 REUAXQZIRFXQML-SSDOTTSWSA-N 0.000 description 1
- HBVNLKQGRZPGRP-NSHDSACASA-N (3s)-1-benzylpyrrolidin-3-amine Chemical compound C1[C@@H](N)CCN1CC1=CC=CC=C1 HBVNLKQGRZPGRP-NSHDSACASA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CGXOAAMIQPDTPE-UHFFFAOYSA-N 1,2,2,6,6-pentamethylpiperidin-4-amine Chemical compound CN1C(C)(C)CC(N)CC1(C)C CGXOAAMIQPDTPE-UHFFFAOYSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- YKFBBBPAQZPPQT-UHFFFAOYSA-N 1-(2,2,2-trifluoroethyl)piperidin-4-amine;hydrochloride Chemical compound Cl.NC1CCN(CC(F)(F)F)CC1 YKFBBBPAQZPPQT-UHFFFAOYSA-N 0.000 description 1
- PBJVKRKGOGOFMF-UHFFFAOYSA-N 1-(2,2-difluoroethyl)piperidin-4-amine;dihydrochloride Chemical compound Cl.Cl.NC1CCN(CC(F)F)CC1 PBJVKRKGOGOFMF-UHFFFAOYSA-N 0.000 description 1
- BNUCAKHAFXRILR-UHFFFAOYSA-N 1-(3-aminopropyl)piperidin-4-ol Chemical compound NCCCN1CCC(O)CC1 BNUCAKHAFXRILR-UHFFFAOYSA-N 0.000 description 1
- HJORCZCMNWLHMB-UHFFFAOYSA-N 1-(3-aminopropyl)pyrrolidin-2-one Chemical compound NCCCN1CCCC1=O HJORCZCMNWLHMB-UHFFFAOYSA-N 0.000 description 1
- NLHBHVGPMMXWIM-UHFFFAOYSA-N 1-(4-aminopiperidin-1-yl)ethanone Chemical compound CC(=O)N1CCC(N)CC1 NLHBHVGPMMXWIM-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- SZAYRHIIHNUBPP-UHFFFAOYSA-N 1-amino-3-piperazin-1-ylpropan-2-ol Chemical compound NCC(O)CN1CCNCC1 SZAYRHIIHNUBPP-UHFFFAOYSA-N 0.000 description 1
- YUBDLZGUSSWQSS-UHFFFAOYSA-N 1-benzylpiperidin-4-amine Chemical compound C1CC(N)CCN1CC1=CC=CC=C1 YUBDLZGUSSWQSS-UHFFFAOYSA-N 0.000 description 1
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical group [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 1
- BIWZYRJXBPPLLA-UHFFFAOYSA-N 1-methylazetidin-3-amine Chemical compound CN1CC(N)C1 BIWZYRJXBPPLLA-UHFFFAOYSA-N 0.000 description 1
- KJWNKJWHMQSPNZ-UHFFFAOYSA-N 1-methylpiperidin-2-amine Chemical compound CN1CCCCC1N KJWNKJWHMQSPNZ-UHFFFAOYSA-N 0.000 description 1
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 description 1
- FLQSRSQNICPZIH-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-amine Chemical compound CS(=O)(=O)N1CCC(N)CC1 FLQSRSQNICPZIH-UHFFFAOYSA-N 0.000 description 1
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalene Chemical compound C1=CC=C2C(C=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- CZINLSYKXBADTA-UHFFFAOYSA-N 1-pyridin-2-ylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1=CC=CC=N1 CZINLSYKXBADTA-UHFFFAOYSA-N 0.000 description 1
- BTDZSVPICJLNIN-UHFFFAOYSA-N 1-pyridin-4-ylpiperidin-4-amine Chemical compound C1CC(N)CCN1C1=CC=NC=C1 BTDZSVPICJLNIN-UHFFFAOYSA-N 0.000 description 1
- RTMMSCJWQYWMNK-UHFFFAOYSA-N 2,2,2-trifluoroethyl trifluoromethanesulfonate Chemical compound FC(F)(F)COS(=O)(=O)C(F)(F)F RTMMSCJWQYWMNK-UHFFFAOYSA-N 0.000 description 1
- FTVFPPFZRRKJIH-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidin-4-amine Chemical compound CC1(C)CC(N)CC(C)(C)N1 FTVFPPFZRRKJIH-UHFFFAOYSA-N 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- PNHGJPJOMCXSKN-UHFFFAOYSA-N 2-(1-methylpyrrolidin-2-yl)ethanamine Chemical compound CN1CCCC1CCN PNHGJPJOMCXSKN-UHFFFAOYSA-N 0.000 description 1
- NMWIFNPFFNFXPB-UHFFFAOYSA-N 2-(4-aminopiperidin-1-yl)ethanol Chemical compound NC1CCN(CCO)CC1 NMWIFNPFFNFXPB-UHFFFAOYSA-N 0.000 description 1
- GOWUDHPKGOIDIX-UHFFFAOYSA-N 2-(4-methyl-1-piperazinyl)ethanamine Chemical compound CN1CCN(CCN)CC1 GOWUDHPKGOIDIX-UHFFFAOYSA-N 0.000 description 1
- WKJOQYHMXRVQDK-UHFFFAOYSA-N 2-(dimethylamino)acetamide Chemical compound CN(C)CC(N)=O WKJOQYHMXRVQDK-UHFFFAOYSA-N 0.000 description 1
- MXZROAOUCUVNHX-UHFFFAOYSA-N 2-Aminopropanol Chemical compound CCC(N)O MXZROAOUCUVNHX-UHFFFAOYSA-N 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- BQQVEASFNMRTBA-UHFFFAOYSA-N 2-[4-(3-aminopropyl)piperazin-1-yl]ethanol Chemical compound NCCCN1CCN(CCO)CC1 BQQVEASFNMRTBA-UHFFFAOYSA-N 0.000 description 1
- OFCBNMYNAHUDGE-UHFFFAOYSA-N 2-chloro-5-nitropyrimidine Chemical compound [O-][N+](=O)C1=CN=C(Cl)N=C1 OFCBNMYNAHUDGE-UHFFFAOYSA-N 0.000 description 1
- AHJZAWIFZSBGKJ-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-7,7-difluoro-5-methyl-8h-pyrimido[4,5-b][1,4]diazepin-6-one Chemical compound C1C(F)(F)C(=O)N(C)C2=CN=C(Cl)N=C2N1C1CCCC1 AHJZAWIFZSBGKJ-UHFFFAOYSA-N 0.000 description 1
- BPGIOCZAQDIBPI-UHFFFAOYSA-N 2-ethoxyethanamine Chemical compound CCOCCN BPGIOCZAQDIBPI-UHFFFAOYSA-N 0.000 description 1
- MTEZLAATISORQK-UHFFFAOYSA-N 2-methoxyacetamide Chemical compound COCC(N)=O MTEZLAATISORQK-UHFFFAOYSA-N 0.000 description 1
- MFNXWZGIFWJHMI-UHFFFAOYSA-N 2-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C)(C)C(O)=O MFNXWZGIFWJHMI-UHFFFAOYSA-N 0.000 description 1
- UQOKRDJILZMZKU-UHFFFAOYSA-N 2-nitropyrimidine Chemical compound [O-][N+](=O)C1=NC=CC=N1 UQOKRDJILZMZKU-UHFFFAOYSA-N 0.000 description 1
- CJNRGSHEMCMUOE-UHFFFAOYSA-N 2-piperidin-1-ylethanamine Chemical compound NCCN1CCCCC1 CJNRGSHEMCMUOE-UHFFFAOYSA-N 0.000 description 1
- XPQIPUZPSLAZDV-UHFFFAOYSA-N 2-pyridylethylamine Chemical compound NCCC1=CC=CC=N1 XPQIPUZPSLAZDV-UHFFFAOYSA-N 0.000 description 1
- WRXNJTBODVGDRY-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanamine Chemical compound NCCN1CCCC1 WRXNJTBODVGDRY-UHFFFAOYSA-N 0.000 description 1
- HVLUYXIJZLDNIS-UHFFFAOYSA-N 2-thiophen-2-ylethanamine Chemical compound NCCC1=CC=CS1 HVLUYXIJZLDNIS-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- YUCHBNPEXIKPHN-UHFFFAOYSA-N 2h-pyran-4-amine Chemical compound NC1=CCOC=C1 YUCHBNPEXIKPHN-UHFFFAOYSA-N 0.000 description 1
- LNVWRBNPXCUYJI-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazol-4-amine Chemical compound CC1=NNC(C)=C1N LNVWRBNPXCUYJI-UHFFFAOYSA-N 0.000 description 1
- YYAYTNPNFKPFNG-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propan-1-amine Chemical compound CC1CCCCN1CCCN YYAYTNPNFKPFNG-UHFFFAOYSA-N 0.000 description 1
- RGUABPVONIGVAT-UHFFFAOYSA-N 3-(4-methylpiperazin-1-yl)propan-1-amine Chemical compound CN1CCN(CCCN)CC1 RGUABPVONIGVAT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 229940105325 3-dimethylaminopropylamine Drugs 0.000 description 1
- FAXDZWQIWUSWJH-UHFFFAOYSA-N 3-methoxypropan-1-amine Chemical compound COCCCN FAXDZWQIWUSWJH-UHFFFAOYSA-N 0.000 description 1
- UIKUBYKUYUSRSM-UHFFFAOYSA-N 3-morpholinopropylamine Chemical compound NCCCN1CCOCC1 UIKUBYKUYUSRSM-UHFFFAOYSA-N 0.000 description 1
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
- VPBWZBGZWHDNKL-UHFFFAOYSA-N 3-pyrrolidin-1-ylpropan-1-amine Chemical compound NCCCN1CCCC1 VPBWZBGZWHDNKL-UHFFFAOYSA-N 0.000 description 1
- IXJFWBNYFTWBOR-UHFFFAOYSA-N 4-amino-3-(trifluoromethoxy)benzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1OC(F)(F)F IXJFWBNYFTWBOR-UHFFFAOYSA-N 0.000 description 1
- YIYBPEDZAUFQLO-UHFFFAOYSA-N 4-amino-3-chlorobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1Cl YIYBPEDZAUFQLO-UHFFFAOYSA-N 0.000 description 1
- ZSXBMWHEQHCCRP-UHFFFAOYSA-N 4-amino-3-ethoxybenzoic acid Chemical compound CCOC1=CC(C(O)=O)=CC=C1N ZSXBMWHEQHCCRP-UHFFFAOYSA-N 0.000 description 1
- MFTBLGQBZWFKHP-UHFFFAOYSA-N 4-amino-3-ethylbenzoic acid Chemical compound CCC1=CC(C(O)=O)=CC=C1N MFTBLGQBZWFKHP-UHFFFAOYSA-N 0.000 description 1
- JSKXHTHMCCDEGD-UHFFFAOYSA-N 4-amino-3-fluorobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1F JSKXHTHMCCDEGD-UHFFFAOYSA-N 0.000 description 1
- KSZFQSAUVGYGQE-UHFFFAOYSA-N 4-amino-3-methoxy-n-[1-(3-methylsulfonylpropyl)piperidin-4-yl]benzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NC2CCN(CCCS(C)(=O)=O)CC2)=C1 KSZFQSAUVGYGQE-UHFFFAOYSA-N 0.000 description 1
- NHFKECPTBZZFBC-UHFFFAOYSA-N 4-amino-3-methylbenzoic acid Chemical compound CC1=CC(C(O)=O)=CC=C1N NHFKECPTBZZFBC-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- RJWLLQWLBMJCFD-UHFFFAOYSA-N 4-methylpiperazin-1-amine Chemical compound CN1CCN(N)CC1 RJWLLQWLBMJCFD-UHFFFAOYSA-N 0.000 description 1
- MOAIDLUWFCXIJA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-piperidin-4-ylcarbamate;hydrochloride Chemical compound Cl.C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)NC1CCNCC1 MOAIDLUWFCXIJA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- 230000010337 G2 phase Effects 0.000 description 1
- 230000037060 G2 phase arrest Effects 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- OCAFBWCIHWDTKE-UHFFFAOYSA-N [dimethylamino-(3-oxidobenzotriazol-3-ium-1-yl)methylidene]-dimethylazanium Chemical compound C1=CC=C2[N+](=C(N(C)C)N(C)C)N=[N+]([O-])C2=C1 OCAFBWCIHWDTKE-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- HYZHPAXFOXQGMV-UHFFFAOYSA-N benzotriazol-1-ylmethanamine Chemical compound C1=CC=C2N(CN)N=NC2=C1 HYZHPAXFOXQGMV-UHFFFAOYSA-N 0.000 description 1
- IRKGMFWANMCSOS-VXGBXAGGSA-N benzyl (3r,4r)-4-amino-3-hydroxypiperidine-1-carboxylate Chemical compound C1[C@@H](O)[C@H](N)CCN1C(=O)OCC1=CC=CC=C1 IRKGMFWANMCSOS-VXGBXAGGSA-N 0.000 description 1
- XOCCDWVWMPSHJU-VXGBXAGGSA-N benzyl (3r,4r)-4-azido-3-hydroxypiperidine-1-carboxylate Chemical compound C1C[C@@H](N=[N+]=[N-])[C@H](O)CN1C(=O)OCC1=CC=CC=C1 XOCCDWVWMPSHJU-VXGBXAGGSA-N 0.000 description 1
- VKBBZJXAWNVLSE-RYUDHWBXSA-N benzyl (3s,4s)-3-amino-4-hydroxypiperidine-1-carboxylate Chemical compound C1C[C@H](O)[C@@H](N)CN1C(=O)OCC1=CC=CC=C1 VKBBZJXAWNVLSE-RYUDHWBXSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- AVKNGPAMCBSNSO-UHFFFAOYSA-N cyclohexylmethanamine Chemical compound NCC1CCCCC1 AVKNGPAMCBSNSO-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- YOTZYFSGUCFUKA-UHFFFAOYSA-N dimethylphosphine Chemical compound CPC YOTZYFSGUCFUKA-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- DYLIOPUQECWBCX-UHFFFAOYSA-N ethyl 2,2-difluoro-3-(2-thiophen-2-ylethylamino)propanoate Chemical compound CCOC(=O)C(F)(F)CNCCC1=CC=CS1 DYLIOPUQECWBCX-UHFFFAOYSA-N 0.000 description 1
- BLVDKSNGRNNQIM-UHFFFAOYSA-N ethyl 2,2-difluoro-3-(3-phenylpropylamino)propanoate Chemical compound CCOC(=O)C(F)(F)CNCCCC1=CC=CC=C1 BLVDKSNGRNNQIM-UHFFFAOYSA-N 0.000 description 1
- IYMOTMOFRHGDLM-UHFFFAOYSA-N ethyl 2,2-difluoro-3-[(4-methoxyphenyl)methylamino]propanoate Chemical compound CCOC(=O)C(F)(F)CNCC1=CC=C(OC)C=C1 IYMOTMOFRHGDLM-UHFFFAOYSA-N 0.000 description 1
- ALDYUVNBHFZLIT-NWDGAFQWSA-N ethyl 2,2-difluoro-3-[[(1r,2s)-2-phenylcyclopropyl]amino]propanoate Chemical compound CCOC(=O)C(F)(F)CN[C@@H]1C[C@H]1C1=CC=CC=C1 ALDYUVNBHFZLIT-NWDGAFQWSA-N 0.000 description 1
- NYXJZKHYHIPYOV-UHFFFAOYSA-N ethyl 3-[(2-chloro-5-nitropyrimidin-4-yl)-cyclobutylamino]-2,2-difluoropropanoate Chemical compound N=1C(Cl)=NC=C([N+]([O-])=O)C=1N(CC(F)(F)C(=O)OCC)C1CCC1 NYXJZKHYHIPYOV-UHFFFAOYSA-N 0.000 description 1
- AZLPEJUVWWGLHA-UHFFFAOYSA-N ethyl acetate;hexane;methanol Chemical compound OC.CCCCCC.CCOC(C)=O AZLPEJUVWWGLHA-UHFFFAOYSA-N 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- DDRPCXLAQZKBJP-UHFFFAOYSA-N furfurylamine Chemical compound NCC1=CC=CO1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical class CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- VHFUHRXYRYWELT-UHFFFAOYSA-N methyl 2,2,2-trichloroacetate Chemical compound COC(=O)C(Cl)(Cl)Cl VHFUHRXYRYWELT-UHFFFAOYSA-N 0.000 description 1
- XBUVRWIIEREYFL-UHFFFAOYSA-N methyl 2,5-difluoro-4-nitrobenzoate Chemical compound COC(=O)C1=CC(F)=C([N+]([O-])=O)C=C1F XBUVRWIIEREYFL-UHFFFAOYSA-N 0.000 description 1
- UEGCRFNWTGYVKX-UHFFFAOYSA-N methyl 3-hydroxy-4-nitrobenzoate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)C(O)=C1 UEGCRFNWTGYVKX-UHFFFAOYSA-N 0.000 description 1
- RRIRDPSOCUCGBV-UHFFFAOYSA-N methylenedioxyphenethylamine Chemical compound NCCC1=CC=C2OCOC2=C1 RRIRDPSOCUCGBV-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- ULDIVZQLPBUHAG-UHFFFAOYSA-N n',n',2,2-tetramethylpropane-1,3-diamine Chemical compound CN(C)CC(C)(C)CN ULDIVZQLPBUHAG-UHFFFAOYSA-N 0.000 description 1
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
- ITZPOSYADVYECJ-UHFFFAOYSA-N n'-cyclohexylpropane-1,3-diamine Chemical compound NCCCNC1CCCCC1 ITZPOSYADVYECJ-UHFFFAOYSA-N 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- OCIDXARMXNJACB-UHFFFAOYSA-N n'-phenylethane-1,2-diamine Chemical compound NCCNC1=CC=CC=C1 OCIDXARMXNJACB-UHFFFAOYSA-N 0.000 description 1
- KFDIDIIKNMZLRZ-UHFFFAOYSA-N n'-propan-2-ylpropane-1,3-diamine Chemical compound CC(C)NCCCN KFDIDIIKNMZLRZ-UHFFFAOYSA-N 0.000 description 1
- CZFNISFYDPIDNM-UHFFFAOYSA-N n,n-dimethylformamide;oxolane Chemical compound CN(C)C=O.C1CCOC1 CZFNISFYDPIDNM-UHFFFAOYSA-N 0.000 description 1
- SVVQVPJHZKHQIX-UHFFFAOYSA-N n-(benzotriazol-1-ylmethyl)-2-thiophen-2-ylethanamine Chemical compound N1=NC2=CC=CC=C2N1CNCCC1=CC=CS1 SVVQVPJHZKHQIX-UHFFFAOYSA-N 0.000 description 1
- LEYWRYHAZXRHIB-UHFFFAOYSA-N n-(oxan-4-yl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NC1CCOCC1 LEYWRYHAZXRHIB-UHFFFAOYSA-N 0.000 description 1
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 1
- WRJYRNIARRMKLN-UHFFFAOYSA-N n-cyclopentylpiperidin-4-amine Chemical compound C1CCCC1NC1CCNCC1 WRJYRNIARRMKLN-UHFFFAOYSA-N 0.000 description 1
- RUFSHRICEZJQDT-UHFFFAOYSA-N n-cyclopropylpiperidin-4-amine Chemical compound C1CC1NC1CCNCC1 RUFSHRICEZJQDT-UHFFFAOYSA-N 0.000 description 1
- VARJMVYCDHQKCG-UHFFFAOYSA-N n-ethylpiperidin-4-amine Chemical compound CCNC1CCNCC1 VARJMVYCDHQKCG-UHFFFAOYSA-N 0.000 description 1
- GINABUAPACIWCA-UHFFFAOYSA-N n-propan-2-ylpiperidin-4-amine Chemical compound CC(C)NC1CCNCC1 GINABUAPACIWCA-UHFFFAOYSA-N 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- YLQBPWQRPIJFPO-UHFFFAOYSA-N n-propylimidazol-1-amine Chemical compound CCCNN1C=CN=C1 YLQBPWQRPIJFPO-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940117803 phenethylamine Drugs 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- LWMPFIOTEAXAGV-UHFFFAOYSA-N piperidin-1-amine Chemical compound NN1CCCCC1 LWMPFIOTEAXAGV-UHFFFAOYSA-N 0.000 description 1
- SGQDWDWJCYEUNC-UHFFFAOYSA-N piperidin-1-ium-4-ylazanium;dichloride Chemical compound Cl.Cl.NC1CCNCC1 SGQDWDWJCYEUNC-UHFFFAOYSA-N 0.000 description 1
- KBOGICFUPOMDKS-UHFFFAOYSA-N piperidin-4-ylcarbamic acid Chemical compound OC(=O)NC1CCNCC1 KBOGICFUPOMDKS-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- MOZOQDNRVPHFOO-RNFRBKRXSA-N tert-butyl (3r,4r)-3-amino-4-hydroxypyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1C[C@@H](N)[C@H](O)C1 MOZOQDNRVPHFOO-RNFRBKRXSA-N 0.000 description 1
- QNGHCFVWYKWWMU-DTWKUNHWSA-N tert-butyl (3r,4s)-4-amino-3-methoxypiperidine-1-carboxylate Chemical compound CO[C@@H]1CN(C(=O)OC(C)(C)C)CC[C@@H]1N QNGHCFVWYKWWMU-DTWKUNHWSA-N 0.000 description 1
- GEHBIWVQKQLYNB-UHFFFAOYSA-N tert-butyl 2-aminopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1N GEHBIWVQKQLYNB-UHFFFAOYSA-N 0.000 description 1
- XSJPKMUFBHSIRA-UHFFFAOYSA-N tert-butyl 3-(aminomethyl)azetidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC(CN)C1 XSJPKMUFBHSIRA-UHFFFAOYSA-N 0.000 description 1
- OGCCBDIYOAFOGK-UHFFFAOYSA-N tert-butyl 3-(aminomethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CN)C1 OGCCBDIYOAFOGK-UHFFFAOYSA-N 0.000 description 1
- WPGLRFGDZJSQGI-UHFFFAOYSA-N tert-butyl 3-aminoazetidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC(N)C1 WPGLRFGDZJSQGI-UHFFFAOYSA-N 0.000 description 1
- DNMYILASPHUVFX-UHFFFAOYSA-N tert-butyl 4-(3-amino-2-hydroxypropyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(CC(O)CN)CC1 DNMYILASPHUVFX-UHFFFAOYSA-N 0.000 description 1
- DQLCYLFCLQPLSY-UHFFFAOYSA-N tert-butyl 4-(3-aminopropyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(CCCN)CC1 DQLCYLFCLQPLSY-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FEYLUKDSKVSMSZ-UHFFFAOYSA-N tert-butyl n-(4-aminocyclohexyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1CCC(N)CC1 FEYLUKDSKVSMSZ-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- DUDAKCCDHRNMDJ-UHFFFAOYSA-N thiophen-3-ylmethanamine Chemical compound NCC=1C=CSC=1 DUDAKCCDHRNMDJ-UHFFFAOYSA-N 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7338808P | 2008-06-18 | 2008-06-18 | |
| US61/073,388 | 2008-06-18 | ||
| PCT/EP2009/057144 WO2009153197A1 (en) | 2008-06-18 | 2009-06-10 | Halo-substituted pyrimidodiazepines as plkl inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011527667A true JP2011527667A (ja) | 2011-11-04 |
| JP2011527667A5 JP2011527667A5 (enExample) | 2012-08-02 |
Family
ID=41431858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513994A Abandoned JP2011527667A (ja) | 2008-06-18 | 2009-06-10 | ハロ置換ピリミドジアゼピン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8003785B2 (enExample) |
| EP (1) | EP2303889A1 (enExample) |
| JP (1) | JP2011527667A (enExample) |
| WO (1) | WO2009153197A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ584760A (en) * | 2007-09-25 | 2012-03-30 | Takeda Pharmaceutical | Polo-like kinase inhibitors |
| EP2361242B1 (en) | 2008-10-17 | 2018-08-01 | Oryzon Genomics, S.A. | Oxidase inhibitors and their use |
| WO2010084160A1 (en) | 2009-01-21 | 2010-07-29 | Oryzon Genomics S.A. | Phenylcyclopropylamine derivatives and their medical use |
| AU2010299579A1 (en) * | 2009-09-25 | 2012-05-03 | Vertex Pharmaceuticals Incorporated | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| NZ599342A (en) | 2009-09-25 | 2014-04-30 | Vertex Pharma | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors |
| KR101736218B1 (ko) | 2009-09-25 | 2017-05-16 | 오리존 지노믹스 에스.에이. | 라이신 특이적 디메틸라아제-1 억제제 및 이의 용도 |
| EP2486002B1 (en) | 2009-10-09 | 2019-03-27 | Oryzon Genomics, S.A. | Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use |
| JP5504898B2 (ja) * | 2010-01-08 | 2014-05-28 | セントラル硝子株式会社 | ジフルオロシクロプロパン化合物の製造方法 |
| WO2011106574A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Inhibitors for antiviral use |
| US9186337B2 (en) | 2010-02-24 | 2015-11-17 | Oryzon Genomics S.A. | Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae |
| ES2607081T3 (es) | 2010-04-19 | 2017-03-29 | Oryzon Genomics, S.A. | Inhibidores de desmetilasa específica de lisina-1 y su uso |
| US9006449B2 (en) | 2010-07-29 | 2015-04-14 | Oryzon Genomics, S.A. | Cyclopropylamine derivatives useful as LSD1 inhibitors |
| LT2598482T (lt) | 2010-07-29 | 2018-07-10 | Oryzon Genomics, S.A. | Demetilazės lsd1 inhibitoriai arilciklopropilamino pagrindu ir jų medicininis panaudojimas |
| US9061966B2 (en) | 2010-10-08 | 2015-06-23 | Oryzon Genomics S.A. | Cyclopropylamine inhibitors of oxidases |
| WO2012072713A2 (en) | 2010-11-30 | 2012-06-07 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae |
| WO2012107498A1 (en) | 2011-02-08 | 2012-08-16 | Oryzon Genomics S.A. | Lysine demethylase inhibitors for myeloproliferative disorders |
| SI2776394T1 (sl) | 2011-10-20 | 2019-05-31 | Oryzon Genomics, S.A. | Spojine (hetero)aril ciklopropilamina kot inhibitorji LSD1 |
| EP3736265A1 (en) | 2011-10-20 | 2020-11-11 | Oryzon Genomics, S.A. | (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| CA2873097A1 (en) | 2012-05-11 | 2013-11-14 | Todd M. Hansen | Pyridazine and pyridine derivatives as nampt inhibitors |
| CA2918910A1 (en) | 2013-07-25 | 2015-01-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
| JP2017504651A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジアゼパン誘導体の使用 |
| KR20160115953A (ko) | 2014-01-31 | 2016-10-06 | 다나-파버 캔서 인스티튜트 인크. | 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도 |
| JP2017526741A (ja) | 2014-08-08 | 2017-09-14 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | ジアゼパン誘導体およびその使用 |
| CN105646398B (zh) * | 2014-12-05 | 2018-09-07 | 上海医药工业研究院 | N-((1r,4r)-4-(4-(环丙基甲基)哌嗪-1-基)环己基)乙酰胺的制备方法 |
| WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| PE20181287A1 (es) | 2015-09-11 | 2018-08-07 | Dana Farber Cancer Inst Inc | Ciano tienotriazolpirazinas y usos de las mismas |
| HK1256419A1 (zh) | 2015-09-11 | 2019-09-20 | 达纳-法伯癌症研究所股份有限公司 | 乙酰胺噻吩並三唑並二氮雜環庚三烯及其用途 |
| SG10201913450PA (en) | 2015-11-25 | 2020-03-30 | Dana Farber Cancer Inst Inc | Bivalent bromodomain inhibitors and uses thereof |
| US20230158158A1 (en) * | 2020-03-27 | 2023-05-25 | Uppthera | Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1 |
| WO2022145989A1 (ko) * | 2020-12-31 | 2022-07-07 | (주) 업테라 | 선택적 plk1 억제제로서의 피리미도디아제핀 유도체 |
| CA3228601A1 (en) * | 2021-08-10 | 2023-02-16 | Soo Hee RYU | Novel plk1 degradation inducing compound |
| GB202313514D0 (en) | 2023-09-05 | 2023-10-18 | Cambridge Entpr Ltd | Treatment of inflammatory diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7491400A (en) | 1999-09-17 | 2001-04-17 | Abbott Gmbh & Co. Kg | Kinase inhibitors as therapeutic agents |
| NZ531928A (en) | 2001-09-04 | 2005-10-28 | Boehringer Ingelheim Pharma | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| US6806272B2 (en) * | 2001-09-04 | 2004-10-19 | Boehringer Ingelheim Pharma Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| KR20080095902A (ko) | 2006-02-14 | 2008-10-29 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제의 억제제로서 유용한 디하이드로디아제핀 |
| TW200808325A (en) * | 2006-07-06 | 2008-02-16 | Astrazeneca Ab | Novel compounds |
| PT2139892E (pt) * | 2007-03-22 | 2011-11-21 | Takeda Pharmaceutical | Pirimidodiazepinas substituídas úteis como inibidores da plk1 |
| NZ584760A (en) * | 2007-09-25 | 2012-03-30 | Takeda Pharmaceutical | Polo-like kinase inhibitors |
-
2009
- 2009-06-10 EP EP09765777A patent/EP2303889A1/en not_active Withdrawn
- 2009-06-10 JP JP2011513994A patent/JP2011527667A/ja not_active Abandoned
- 2009-06-10 WO PCT/EP2009/057144 patent/WO2009153197A1/en not_active Ceased
- 2009-06-16 US US12/485,108 patent/US8003785B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2303889A1 (en) | 2011-04-06 |
| US20090318408A1 (en) | 2009-12-24 |
| US8003785B2 (en) | 2011-08-23 |
| WO2009153197A1 (en) | 2009-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8003785B2 (en) | Halo-substituted pyrimidodiazepines | |
| US11053218B2 (en) | 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | |
| EP3820574B1 (en) | 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases | |
| US7935706B2 (en) | Nitrogen-containing heterocycle derivatives substituted with cyclic group | |
| US10196390B2 (en) | TYK2 inhibitors and uses thereof | |
| US20110288067A1 (en) | Pyrrolopyrazine Kinase Inhibitors | |
| EP3164401B1 (en) | New spiro[3h-indole-3,2´-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors | |
| US8962642B2 (en) | 5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors | |
| US9212190B2 (en) | IRAK inhibitors and uses thereof | |
| JP2016519673A (ja) | ヘテロアリール化合物およびそれらの使用 | |
| TW202325290A (zh) | 作為骨髓細胞上表現之觸發受體2促效劑之雜環化合物及其使用方法 | |
| CN101420955A (zh) | 可用作蛋白激酶抑制剂的二氢二氮杂 | |
| TW202220958A (zh) | Trpml調節劑 | |
| US20230026466A1 (en) | Wdr5 inhibitors and modulators | |
| US20250170126A1 (en) | Novel b0at1 inhibitor | |
| TW202321228A (zh) | 苯並二噁烷類化合物、其製備方法與應用 | |
| US20240190890A1 (en) | Mk2 inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120611 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120611 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20131227 |